Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 59
Encontrada(s) 1 página(s)

BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

Cardiovascular Response and Locomotor Demands of Elite Basketball Referees During International Tournament: A Within- and Between-Referee Analysis

  • Pojskić, Haris
  • Užičanin, Edin
  • Suárez Iglesias, David
  • Vaquera Jiménez, Alejandro
[EN] There is little knowledge about within- and between-referee variation (WBRV) in cardiovascular responses (CVR) and locomotor game demands (LMD). Thus, the primary aim of this study was to assess the WBRV of CVR and LMD in male basketball referees during elite international games in preparation [e.g., warm-up (WU) and re-warm-up (R-WU)] and active game phases. The secondary aim was to explore quarter-by-quarter differences in CVR and LMD. Thirty-five international male referees took part in this study (age, 40.4 ± 5.4 years; body height, 184.9 ± 5.7 cm; body weight, 85.1 ± 7.5 kg; BMI, 24.0 ± 1.7 kg × m−2; fat%, 18.8 ± 4.7% and VO2max, 50.4 ± 2.2 L × kg−1 × min−1. In total, 76 games (e.g., 228 officiating cases) were analyzed during the FIBA elite men’s competition. They officiated 4.5 games on average (range 3–9 games). Each referee used the Polar Team Pro system to measure CVR [e.g., heart rate (HR), time spent in different HR intensity categories] and LMD (e.g., distance covered, maximal and average velocity, and number of accelerations). Results showed that the referees had bigger WBRV during the active and preparation (e.g., W-U than R-WU) phase when variables of higher CVR and LMD intensity were observed (e.g., time spent at higher HR zones, distance covered in higher speed zones). The WBRV, CVR, and LMD were higher during WU than R-WU. Moreover, the referees had a lower CVR and LMD in the second half. In conclusion, the referees should establish and follow consistently a game-to-game preparation routine and attempt to spread their on-court preparation time equally within the crew. A half-time preparation routine should be improved to re-establish a sufficient activation level similar to that achieved in pre-game preparation., SI, Universidad de Leon, University of Worcester
Docta Complutense
Publication Artículo científico (JournalArticle)

CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition

  • Quijada Álamo, Miguel
  • Hernández Sánchez, María
  • Alonso Pérez, Verónica
  • Rodríguez Vicente, Ana E.
  • García Tuñón, Ignacio
  • Martín Izquierdo, Marta
  • Hernández Sánchez, Jesús María
  • Herrero, Ana B.
  • Bastida, José María
  • San Segundo, Laura
  • Gruber, Michaela
  • García, Juan Luis
  • Yin, Shanye
  • Hacken, Elisa ten
  • Benito, Rocío
  • Ordóñez, José Luis
  • Wu, Catherine J.
  • Hernández-Rivas, Jesús María
The deletion of 11q (del(11q)) invariably comprises ATM gene in chronic lymphocytic leukemia (CLL). Concomitant mutations in this gene in the remaining allele have been identified in 1/3 of CLL cases harboring del(11q), being the biallelic loss of ATM associated with adverse prognosis. Although the introduction of targeted BCR inhibition has significantly favored the outcomes of del(11q) patients, responses of patients harboring ATM functional loss through biallelic inactivation are unexplored, and the development of resistances to targeted therapies have been increasingly reported, urging the need to explore novel therapeutic approaches. Here, we generated isogenic CLL cell lines harboring del(11q) and ATM mutations through CRISPR/Cas9-based gene-editing. With these models, we uncovered a novel therapeutic vulnerability of del(11q)/ ATM-mutated cells to dual BCR and PARP inhibition. Ex vivo studies in the presence of stromal stimulation on 38 CLL primary samples confirmed a synergistic action of the combination of olaparib and ibrutinib in del(11q)/ATM-mutated CLL patients. In addition, we showed that ibrutinib produced a homologous recombination repair impairment through RAD51 dysregulation, finding a synergistic link of both drugs in the DNA damage repair pathway. Our data provide a preclinical rationale for the use of this combination in CLL patients with this high-risk cytogenetic abnormality
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression

  • Medina-Herrera, A.
  • Vazquez, I.
  • Cuenca, I.
  • Rosa-Rosa, J.M.|||0000-0003-0806-6453
  • Ariceta, Beñat|||0000-0001-8819-402X
  • Jimenez, C.
  • Fernandez-Mercado, M.
  • Larrayoz, M.J.
  • Gutierrez, N.C.
  • Fernandez-Guijarro, M.
  • Gonzalez-Calle, V.
  • Rodriguez-Otero, Paula|||0000-0001-5236-7785
  • Oriol, Albert|||0000-0001-6804-2221
  • Rosiñol, Laura|||0000-0002-2534-9239
  • Alegre, Adrian|||0000-0002-2423-822X
  • Escalante, F.
  • de la Rubia, Javier|||0000-0002-8354-768X
  • Teruel, A.I.
  • De Arriba, Felipe|||0000-0002-4451-1318
  • Hernández, Miguel Teodoro|||0000-0002-6576-7881
  • Lopez-Jimenez, Javier|||0000-0002-2969-3002
  • Ocio, Enrique M.|||0000-0002-5765-0085
  • Puig, Noemí|||0000-0001-7535-3861
  • Paiva, Bruno|||0000-0003-1977-3815
  • Lahuerta, J. J.|||0000-0002-3393-9570
  • Bladé Creixenti, Juan|||0000-0002-4563-3405
  • San Miguel, Jesús|||0000-0002-9183-4857
  • Mateos, M. V.|||0000-0003-2390-1218
  • Martínez-López, Joaquín|||0000-0001-7908-0063
  • Calasanz, M.J.|||0000-0002-0374-3008
  • García-Sanz, Ramón|||0000-0003-4120-2787
  • De Arriba, Felipe|||0000-0002-4451-1318
  • Rios, R.
  • Sureda, Anna|||0000-0002-1238-6970
  • Blanchard, María Jesús
  • Martinez-Martinez, R.
  • Moraleda, J. M.
  • Bargay, Joan|||0000-0002-6739-3916
  • Gironella, Meritxell|||0000-0003-4437-5181
  • Palomera, L.
  • Gonzalez-Montes, Y.
  • Martí, J.M.
  • Krsnik, Isabel|||0000-0002-2912-5072
  • Arguiñano, J.M.
  • González Garcia, Maria Esther|||0000-0002-4238-0377
  • Gonzalez, A.P.
  • Casado Montero, Luis Felipe|||0000-0002-8171-0674
Smoldering multiple myeloma (SMM) precedes multiple myeloma (MM). The risk of progression of SMM patients is not uniform, thus different progression-risk models have been developed, although they are mainly based on clinical parameters. Recently, genomic predictors of progression have been defined for untreated SMM. However, the usefulness of such markers in the context of clinical trials evaluating upfront treatment in high-risk SMM (HR SMM) has not been explored yet, precluding the identification of baseline genomic alterations leading to drug resistance. For this reason, we carried out next-generation sequencing and fluorescent in-situ hybridization studies on 57 HR and ultra-high risk (UHR) SMM patients treated in the phase II GEM-CESAR clinical trial (NCT02415413). DIS3, FAM46C, and FGFR3 mutations, as well as t(4;14) and 1q alterations, were enriched in HR SMM. TRAF3 mutations were specifically associated with UHR SMM but identified cases with improved outcomes. Importantly, novel potential predictors of treatment resistance were identified: NRAS mutations and the co-occurrence of t(4;14) plus FGFR3 mutations were associated with an increased risk of biological progression. In conclusion, we have carried out for the first time a molecular characterization of HR SMM patients treated with an intensive regimen, identifying genomic predictors of poor outcomes in this setting.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Preferential Genetic Pathways Lead to Relapses in Adult B-Cell Acute Lymphoblastic Leukemia

  • Navas-Acosta, Josgrey del Valle
  • Hernández-Sánchez, Alberto|||0000-0002-6601-3096
  • González, Teresa
  • Villaverde Ramiro, Ángela|||0000-0002-7337-7218
  • Santos, Sandra
  • Miguel, Cristina|||0000-0001-7359-7993
  • Ribera Salas, Jordi|||0000-0003-4796-6470
  • Granada, Isabel|||0000-0002-4275-0104
  • Morgades, Mireia|||0000-0003-0295-2534
  • Sánchez, Ricardo|||0000-0002-6383-0381
  • Such, Esperanza|||0000-0001-6892-403X
  • Barrena, Susana
  • Ciudad Pizarro, Juana
  • Dávila-Valls, Julio|||0000-0002-5185-2073
  • De las Heras, Natalia|||0000-0002-5188-5350
  • García-de Coca, Alfonso|||0000-0002-4942-060X
  • Labrador, Jorge|||0000-0002-3696-0287
  • Queizán, José Antonio
  • Martín, Sandra
  • Orfao, Alberto|||0000-0002-0007-7230
  • Ribera, Jose-Maria|||0000-0003-1042-6024
  • Benito, Rocío|||0000-0001-9781-4198
  • Hernández Rivas, Jesús María|||0000-0002-9661-9371
Adult B-cell acute lymphoblastic leukemia (B-ALL) is characterized by genetic heterogeneity and a high relapse rate, affecting over 40% of adults. However, the mechanisms leading to relapse in adults are poorly understood. Forty-four adult B-ALL patients were studied at both diagnosis and relapse by next-generation sequencing (NGS). Four main genetic pathways leading to relapse in adults were identified: IKZF1 genetic profile, RAS mutations and TP53 alterations in Ph-negative B-ALL and acquisition of ABL1 mutations in Ph-positive patients. The most frequently deleted gene at diagnosis was IKZF1 (52%), and 70% of these patients had IKZF1 profile. Notably, 88% of patients with IKZF1 at diagnosis retained this genetic profile at relapse. Conversely, the acquisition of RAS mutations or the expansion of subclones (normalized variant allele frequency < 25%) present from diagnosis were observed in 24% of Ph-negative patients at relapse. In addition, 24% of relapses in the Ph-negative cohort could potentially be driven by TP53 alterations. Of these cases, five presented from diagnosis, and four emerged at relapse, mostly as "double-hit" events involving both TP53 deletion and mutation. In Ph-positive B-ALL, the main genetic finding at relapse was the acquisition of ABL1 mutations (86%). Three clonal evolution patterns were identified: the persistent clone trajectory (25%), the expanding clone trajectory (11%) and the therapy-boosted trajectory (48%). Our results reveal the presence of preferential biological pathways leading to relapse in adult B-ALL. These findings underscore the need for personalized therapeutic strategies to improve clinical outcomes in adult patients with B-ALL.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The link between ultra-processed food consumption, fecal microbiota, and metabolomic profiles in older mediterranean adults at high cardiovascular risk

  • Atzeni, Alessandro
  • Hernández-Cacho, Adrián
  • Khoury, Nadine
  • Babio, Nancy|||0000-0003-3527-5277
  • Belzer, Clara
  • Vioque, Jesús|||0000-0002-2284-148X
  • Corella, Dolores|||0000-0002-2366-4104
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Clish, Clary|||0000-0001-8259-9245
  • Vidal, Josep|||0000-0002-4564-4518
  • Konstanti, Prokopis
  • Gonzales-Palacios, Sandra
  • Coltell, Oscar
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Moreno Indias, Isabel
  • Carlos Chillerón, Silvia
  • Ruiz-Canela, Miguel|||0000-0002-7684-2787
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Hu, Frank B.
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
Ultra-processed food (UPF) consumption has been linked to adverse metabolic outcomes, potentially mediated by alterations in gut microbiota and metabolite production. This study aims to explore the cross-sectional and longitudinal associations between NOVA-classified UPF consumption, fecal microbiota, and fecal metabolome in a population of Mediterranean older adults at high cardiovascular risk. A total of 385 individuals, aged between 55 and 75 years, were included in the study. Dietary and lifestyle information, anthropometric measurements, and stool samples were collected at baseline and after 1-year follow-up. Fecal microbiota and metabolome were assessed using 16 S rRNA sequencing and liquid chromatography-tandem mass spectrometry, respectively. At baseline, higher UPF consumption was associated with lower abundance of Ruminococcaceae incertae sedis (β = - 0.275, P = 0.047) and lower concentrations of the metabolites propionylcarnitine (β = - 0.0003, P = 0.013) and pipecolic acid (β = - 0.0003, P = 0.040) in feces. Longitudinally, increased UPF consumption was linked to reduced abundance of Parabacteroides spp. after a 1-year follow-up (β = - 0.278, P = 0.002). High UPF consumption was associated with less favorable gut microbiota and metabolite profiles, suggesting a possible link to reduced short-chain fatty acid (SCFA) production, altered mitochondrial energy metabolism, and impaired amino acid metabolism. These findings support the reduction of UPF consumption and the promotion of dietary patterns rich in fiber for better gut health. Further research is needed to confirm these associations and clarify the underlying mechanisms. : ISRCTN89898870 (10.1186/ISRCTN89898870). The online version contains supplementary material available at 10.1186/s12937-025-01125-5.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Comprehensive analysis of the relationship between ultra-processed food consumption and food addiction at one-year follow-up in older adults with metabolic syndrome

  • Camacho-Barcia, Lucía|||0000-0002-5989-936X
  • Jiménez Murcia, Susana|||0000-0002-3596-8033
  • Granero, Roser|||0000-0001-6308-3198
  • Torre, Rafael de la|||0000-0002-6765-1866
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Pintó, Xavier|||0000-0002-2216-2444
  • Corella, Dolores|||0000-0002-2366-4104
  • Bes-Rastrollo, Maira|||0000-0002-9139-4206
  • Asensio, Eva Maria|||0000-0003-4558-0988
  • Esteve-Luque, Virginia|||0000-0002-7631-8301
  • Forcano, Laura|||0000-0002-8478-1451
  • Vázquez-Lorente, Héctor|||0000-0003-0183-6902
  • Gómez-Martínez, Carlos|||0000-0002-3077-6702
  • Gomis-González, Maria|||0000-0001-9778-4849
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
BACKGROUND: Ultra-processed foods (UPFs) are theorised to exhibit addictive properties within the framework of the Food Addiction (FA) model, attributable to their high palatability, sugars, salt, saturated/trans fats, and caloric density. AIMS: To evaluate the association between UPFs consumption and FA presence, and to examine whether reducing UPFs intake after one year of intervention is associated to decreased FA scores. METHODS: The sample included 429 Mediterranean older adults with overweight/obesity and metabolic syndrome from the PREDIMED-Plus-Cognition sub-study. FA presence was evaluated with the Yale Food Addiction Scale 2.0, and the nutritional information through validated food frequency questionnaires. UPFs was categorised according to the NOVA system and divided into consumption tertiles. Data were analysed using repeated measures ANOVA, structural equation modelling, and logistic regression to compare FA changes across tertiles of UPF reduction after one-year follow-up. RESULTS: Baseline YFAS categorisation into three levels (positive-probable-negative) showed significant differences between the second and third tertile of UPFs consumption, with the highest tertile of consumption having greater likelihood of worse FA status. After one year, the likelihood of change in the FA levels was higher only for individuals within the highest decreases in the UPFs consumption (OR = 1.67, p = 0.040). DISCUSSION AND CONCLUSIONS: These findings indicate that a reduction in the consumption of UPFs may contribute to the improvement of FA symptoms, providing novel insights into the association between UPFs and the presence of FA. Future research should focus on populations with higher UPFs consumption and investigating the long-term effects of dietary quality on FA symptoms.
Repisalud
Publication Artículo científico (JournalArticle)

Excessive glycosylation drives thoracic aortic aneurysm formation through integrated stress response.

  • Rochano-Ortiz, Antonio
  • San Sebastián-Jaraba, Irene
  • Zamora, Carmen
  • Simó, Carolina
  • García-Cañas, Virginia
  • Martínez-Albaladejo, Sacramento
  • Fernández-Gómez, María José
  • Marcos-Ríos, Daniel
  • Martínez-Núñez, Patricia
  • Martín-Lorenzo, Marta
  • Velho, Tiago R
  • Ruíz-Rodríguez, María Jesús
  • Leal-Zafra, Amanda
  • Gabandé-Rodríguez, Enrique
  • Martínez-Martínez, Sara
  • Guala, Andrea
  • Lorenzo, Óscar
  • Blanco-Colio, Luis Miguel
  • Martín-Ventura, José Luís
  • Álvarez-Llamas, Gloria
  • Aldamiz-Echevarría, Gonzalo
  • Teixidó-Tura, Gisela
  • Forteza, Alberto
  • Nistal, Juan Francisco
  • Redondo, Juan Miguel
  • Méndez-Barbero, Nerea
  • Mittelbrunn, María
  • Oller, Jorge
Thoracic aortic aneurysms and dissections (TAADs) are depicted by aortic medial degeneration characterized by glycan-rich matrix accumulation. Marfan syndrome (MFS) is the most common inherited connective tissue disorder associated with TAAD. Although vascular smooth muscle cell metabolic dysfunction has emerged as a pathogenic driver of TAAD, surgical repair remains the mainstay of treatment. This study aimed to investigate the role of the hexosamine biosynthetic pathway (HBP) in sporadic and genetic TAAD pathophysiology. Hexosamine biosynthetic pathway activation was analysed in aortas from an MFS mouse model, a β-aminopropionitrile-induced non-genetic TAAD model, and patients with sporadic TAAD using transcriptomic and metabolomic approaches. Aortic dilatation was monitored by ultrasound imaging. Pharmacological inhibition of HBP and integrated stress response (ISR) was performed to assess their therapeutic potential. Hexosamine biosynthetic pathway was up-regulated in both an MFS mouse model and β-aminopropionitrile-induced TAAD, as well as in aortic samples from MFS and sporadic TAAD patients. Enhanced HBP activity contributed to aortic dilatation and medial degeneration via vascular smooth muscle cell dysfunction and ISR activation. Inhibition of HBP or ISR reversed these effects in the MFS model. The HBP-ISR axis drives medial degeneration in TAAD. These findings identify HBP and ISR as a potential target in TAAD of both genetic and non-genetic origin.
Repisalud
Publication Artículo científico (JournalArticle)

Immunoglobulin A/PIGR axis as potential mediators of human abdominal aortic aneurysms revealed by topologically resolved proteomics.

  • Cerro-Pardo, Isabel
  • Núñez, Estefanía
  • Picatoste, Belén
  • Márquez-Gálvez, Cristina
  • Ortega-Villanueva, Lucía
  • Raposo-Gutiérrez, Irene
  • Lindholt, Jes S
  • Blanco-Colio, Luis Miguel
  • Ramiro, Almudena R
  • Vázquez, Jesús
  • Martín-Ventura, José Luis
Abdominal aortic aneurysm (AAA) is an asymptomatic chronic disease of the aorta and its evolution is unpredictable. Despite the existence of several pathological mechanisms contributing to the dilation of the human AAA wall, there is currently no specific therapy to prevent the fatal rupture of the aorta. Our objective was to identify novel mediators and/or biomarkers involved in the instability of the aortic wall that could help to prevent AAA progression. Multiplexed quantitative proteomic analysis of human AAA and healthy aortic wall (medial and adventitial layers) was performed. Results were subsequently validated by western blot and immunohistochemistry, as well as by turbidimetry/ELISA of tissue-conditioned media. In addition, immunoglobulins A1 and A2 (IGA1 and IGA2) plasma levels were analyzed by turbidimetry in a pilot study [controls (n = 22) and AAA patients (n = 22)] and in a validation study with a 6-year follow-up [controls (n = 64) and AAA patients (n = 189)]. In vitro experiments were performed in THP-1-derived macrophages (basal or polarized to M1 or M2). Polymeric immunoglobulin receptor (PIGR) mRNA expression and secretion in macrophages were analyzed by Q-PCR and ELISA, respectively. Finally, the hematopoietic contribution of PIGR was assessed in experimental AAA (Ldlr mice fed an atherogenic diet and 1 μg/Kg/min angiotensin II infusion for 28 days) by bone marrow transplantation experiments. Functional analysis of biological pathways altered in human AAA wall revealed a significant upregulation of components of the adaptive immune response, including IGHA1 and IGHA2, as well as the IGA receptor, PIGR. In addition, IGA2, but not IGA1, plasma levels were significantly increased in a pilot study of AAA patients relative to controls (489 ± 38 vs 344 ± 36 mg/L, p < 0.01). This finding was further validated in a larger cohort, confirming the association of IGA2 with AAA presence independent of risk factors and treatments [OR = 2.140 (1.109-4.130), P < 0.05]. Furthermore, in the validation cohort, elevated IGA2 plasma levels were independently associated with AAA progression [HR = 1.941 (1.108-3.399), p < 0.05]. PIGR colocalized with macrophages in the AAA wall and, PIGR mRNA levels were increased following the differentiation of THP-1 monocytes into macrophages, as well as in M1-polarized THP-1 macrophages compared to M2 macrophages. Pigr deficiency in hematopoietic cells resulted in a significantly reduced AAA incidence (14 vs 57%) and decreased macrophage infiltration (3.5 ± 0.5 vs 5.6 ± 0.7%). Increased IGA and PIGR is observed in the AAA wall. Pigr deficiency in hematopoietic cells decreases AAA progression, suggesting a therapeutic role for PIGR in AAA.
Repisalud
Publication Artículo científico (JournalArticle)

Anthropometric Variables as Mediators of the Association of Changes in Diet and Physical Activity With Inflammatory Profile

  • Cárdenas-Fuentes, Gabriela
  • Lassale, Camille
  • Martínez-González, Miguel Ángel
  • Grau, María
  • Salas-Salvado, Jordi
  • Corella, Dolores
  • Serra-Majem, Lluis
  • Warnberg, Julia
  • Konieczna, Jadwiga
  • Estruch, Ramon
  • Pintó, Xavier
  • Martínez, J Alfredo
  • Vázquez, Clotilde
  • Vidal, Josep
  • Tur, Josep A
  • Diaz-Lopez, Andres
  • Lancova, Hana
  • Fito, Montserrat
  • Schröder, Helmut
Mechanisms underlying the associations of high levels of physical activity (PA) and adherence to the Mediterranean diet (MedDiet) with a better inflammatory profile remain unclear. Our objective was to assess the mediating role of changes in body mass index (BMI) and waist circumference (WC), as markers of body fat in the association of changes in PA and adherence to the MedDiet, with changes in the inflammatory profile. This study included 489 adults, aged 55-75 years, from the PREDIMED-Plus multicenter lifestyle intervention trial. An inflammatory score was calculated, based on 8 blood biomarkers: high-sensitivity C-reactive protein, interleukin 6, interleukin 8, interleukin 18, monocyte chemo-attractant protein-1, C-peptide, leptin, and regulated on activation, normal T-cell-expressed and secreted chemokine. Biomarkers, levels of PA, score of MedDiet adherence, BMI, and WC were measured at baseline and at 1-year follow-up. Linear regression models were fitted according to the Baron and Kenny framework for mediation analysis. Changes in BMI and WC mediated the association of both changes in PA and changes in the MedDiet adherence with the inflammatory score. Body mass index mediated 26% of the association of changes in total PA with the inflammatory profile, and 27% of the association of changes in the MedDiet, while WC mediated 13% and 12% of these associations, respectively. In older adults at high cardiovascular risk, increasing PA levels and adherence to a MedDiet during 1 year were associated with a lower inflammatory score, which was partly mediated by a reduction in body fat. International Standard Randomized Controlled Trial Number: ISRCTN89898870; registration date July 24, 2014, retrospectively registered.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Dynamics of interaction and internalisation of the antifungal protein PeAfpA into Penicillium digitatum morphotypes

  • Giner-Llorca, Moises
  • Ropero-Pérez, Carolina
  • Garrigues-Cubells, Sandra María
  • Thomson, Darren D.
  • Bignell, Elaine M.
  • Manzanares-Mir, Paloma Mª
  • Marcos-Lopez, Jose Francisco
[EN] Antifungal proteins (AFPs) as the highly active PeAfpA from Penicillium expansum or PdAfpB from Penicillium digitatum exert promising antifungal activity, but their mode of action is not fully understood. We characterised the interaction of PeAfpA against P. digitatum, comparing it to the less active PdAfpB. Despite similar effect on conidia germination, PeAfpA did not induce a burst of reactive oxygen species as PdAfpB. Live-cell fluorescence microscopy revealed complex dynamics of interaction and internalisation of both proteins with distinct P. digitatum morphotypes (quiescent conidia, swollen conidia, germlings and hyphae). Labelled PeAfpA co-localised at the cell wall of quiescent conidia, where its localisation was punctate and not uniformly distributed. This pattern changed during germination to a uniform distribution with increased intensity. Conidia from mutants of genes involved in melanin biosynthesis (pksP/alb1 or arp2) showed an altered distribution of PeAfpA but later mimicked the wild type trend of changes during germination. In swollen conidia and germlings, PeAfpA remained attached to the cell wall. In hyphae, PeAfpA was internalised through the growing hyphal tip after binding to the cell wall, in a non-endocytic but energy-dependent process that caused vacuolisation, which preceded cell death. These results may help the development of biofungicides based on AFPs., This work was supported by grant PID2021-125858OB-I00, and the Severo Ochoa Excellence Program CEX2021-001189-S, funded by MCIN/AEI/ 10.13039/501100011033 and by ERDF, a way of making Europe . M.G.L. and C.R.P. were recipients of predoctoral grants FPU19/02066 and ACIF/2021/364 funded by MCIN/AEI/10.13039/501100011033 and by ESF-Investing in Your future and by Conselleria d'Educacio¿ (Generalitat Valenciana, Comunitat Valenciana, Spain), respectively. M.G.L. international exchange was supported by EST23/00233 grant (funded by MCIN/AEI/10.13039/ 501100011033 and by ESF-Investing in Your future) and SEG10314 EMBO Scientific Exchange Grant. S.G. holds a Juan de la Cierva Incorporacion grant (IJC2020-042749-I) from the Spanish Ministerio de Ciencia e Innovacion, ¿ funded by the European Union, NextGenerationEU PRTR. Work undertaken with EMB and DDT was funded by the Medical Research Council Centre for Medical Mycology at the University of Exeter (MR/N006364/2 and MR/V033417/1), that forms part of the National Institute for Health and Care Research (NIHR) Exeter Biomedical Research Centre (BRC), and the BBSRC project grant BB/ V017004/1 to EMB. We thank Jose Mª Coll (IATA) for his technical help in microscopy and Dr. Amparo Tarrega ¿ (IATA) for her expert advice in the statistical analyses.
Repositori Institucional UIB
Publication Artículo científico (JournalArticle)

Physical activity and metabolic syndrome severity among older adults at cardiovascular risk: 1-Year trends

  • Gallardo-Alfaro, Laura
  • Bibiloni, María del Mar
  • Bouzas Cristina
  • Mascaró, Catalina M.
  • Martínez-González, Miguel Ángel
  • Salas-Salvadó, Jordi
  • Corella, Dolores
  • Schröder, Helmut
  • Martínez, J. Alfredo
  • Alonso-Gómez, Ángel M.
  • Wärnberg, Julia
  • Vioque, Jesús
  • Romaguera, Dora
  • López-Miranda, José
  • Estruch, Ramon
  • Tinahones, Francisco J.
  • Lapetra, José
  • Serra-Majem, Luis
  • Bueno-Cavanillas, Aurora
  • Micó, Rafael M.
  • Pintó, Xavier
  • Gaforio, José J.
  • Ortíz-Ramos, María
  • Altés-Boronat, Andreu
  • Luca, Bogdana L.
  • Daimiel, Lidia
  • Ros, Emilio
  • Sayon-Orea, Carmen
  • Becerra-Tomás, Nerea
  • Gimenez-Alba, Ignacio Manuel
  • Castañer, Olga
  • Abete, Itziar
  • Tojal-Sierra, Lucas
  • Pérez-López, Jéssica
  • Torres-Collado, Laura
  • Colom, Antoni
  • Garcia-Rios, Antonio
  • Castro-Barquero, Sara
  • Bernal, Rosa
  • Santos-Lozano, José Manuel
  • Fernandez-Lazaro, César I.
  • Hernández-Alonso, Pablo
  • Saiz, Carmen
  • Zomeño, María Dolores
  • Zulet, Maria Angeles
  • Belló-Mora, Maria C.
  • Basterra-Gortari, F. Javier
  • Canudas, Silvia
  • Goday, Albert
  • Tur, Josep A.
[eng] Background and aims: Modifiable lifestyle factors, such as physical activity (PA) and Mediterranean diet (MD), decrease metabolic syndrome (MetS). The aim was to assess 1-year changes of leisure-time physical activity (LTPA), sedentary behavior, and diet quality according to MetS severity in older population at high cardiovascular risk. Methods and results: Prospective analysis of 55–75-year-old 4359 overweight/obese participants with MetS (PREDIMED-Plus trial) categorized in tertiles according to 1-year changes of a validated MetS severity score (MetSSS). Anthropometrics, visceral adiposity index, triglycerides and glucose index, dietary nutrient intake, biochemical marker levels, dietary inflammatory index, and depression symptoms were measured. Diet quality was assessed by 17-item MD questionnaire. PAs were self-reported using the Minnesota-REGICOR Short Physical Activity Questionnaire and 30-s chair stand test. Sedentary behaviors were measured using the Spanish version of the Nurses’ Health Study questionnaire. After 1-year follow-up, decreasing MetSSS was associated with an anti-inflammatory dietary pattern, high intake of vegetables, fruits, legumes, nuts, whole grain cereals, white fish, and bluefish and low intake of refined cereals, red and processed meat, cookies/sweets, and snacks/ready-to-eat-meals. It resulted in high intake of polyunsaturated fatty acids, omega-3 fatty acids, protein, fiber, vitamins B1, B6, B9, C, D, potassium, magnesium, and phosphorus and low glycemic index and saturated fatty acid, trans fatty acid, and carbohydrates intake. Regarding PA and sedentary behavior, decreasing MetSSS was associated with increased moderate-to-vigorous LTPA, chair stand test, and decreased sedentary and TV-viewing time. Conclusion: Decreasing MetSSS was associated with an anti-inflammatory dietary pattern, high LTPA, high MD adherence, low sedentary time, and low depression risk.
Repositori Institucional UIB
Publication Artículo científico (JournalArticle)

Metabolic syndrome criteria and severity and carbon dioxide (CO2) emissions in an adult population

  • García, S.
  • Pastor, R.
  • Monserrat-Mesquida, M.
  • Álvarez-Álvarez, L.
  • Rubín-García, M.
  • Martínez-González, M.Á.
  • Salas-Salvadó, J.
  • Corella, D.
  • Goday, A.
  • Martínez, J.A.
  • Alonso-Gómez, Ángel M.
  • Wärnberg, J.
  • Vioque, J.
  • Romaguera, D.
  • Lopez-Miranda, J.
  • Estruch, R.
  • Tinahones, F.J.
  • Lapetra, J.
  • Serra-Majem, L.
  • Riquelme-Gallego, B.
  • Pintó, X.
  • Gaforio, J.J.
  • Matía, P.
  • Vidal, J.
  • Vázquez, C.
  • Daimiel, L.
  • Ros, E.
  • Sayón-Orea, C.
  • Guillem-Saiz, P.
  • Valle-Hita, C.
  • Cabanes, R.
  • Abete, Itziar
  • Goicolea-Güemez, L.
  • Gómez-Gracia, E.
  • Tercero-Maciá, C.
  • Colom, A.
  • García-Ríos, A.
  • Castro-Barquero, S.
  • Fernández-García, J.C.
  • Santos-Lozano, J.M.
  • Cenoz, J.C.
  • Barragán, R.
  • Khoury, N.
  • Castañer, O.
  • Zulet, M.Á.
  • Vaquero-Luna, J.
  • Bes-Rastrollo, M.
  • de las Heras-Delgado, S.
  • Ciurana, R.
  • Martín-Sánchez, V.
  • Tur, J.A.
  • Bouzas, C.
[eng] Background: Metabolic syndrome (MetS) has become a growing risk factor of some non-communicable diseases. Increase of greenhouse gas emissions affects the planet. Aims: To assess the association between MetS severity and amount of carbon dioxide (CO2) emitted in an adult population. Design: Cross-sectional study (n = 6646; 55-76-year-old-men; 60-75-year-old-women with MetS). Methods: Dietary habits were assessed using a pre-validated semi quantitative 143-item food frequency questionnaire. The amount of CO2 emitted due to the production of food consumed by person and day was calculated using a European database, and the severity of the MetS was calculated with the MetS Severity Score. Results: Higher glycaemia levels were found in people with higher CO2 emissions. The risk of having high severe MetS was related to high CO2 emissions. Conclusions: Low CO2 emissions diet would help to reduce MetS severity. Advantages for both health and the environment were found following a more sustainable diet.
Repositori Institucional UIB
Publication Artículo científico (JournalArticle)

Does Consumption of Ultra-Processed Foods Matter for Liver Health? Prospective Analysis among Older Adults with Metabolic Syndrome

  • Konieczna, Jadwiga
  • Fiol, Miguel
  • Colom, Antoni
  • Martínez-González, Miguel Ángel
  • Salas-Salvadó, Jordi
  • Corella, Dolores
  • Soria-Florido, María Trinidad
  • Martínez, J. Alfredo
  • Alonso-Gómez, Ángel M.
  • Wärnberg, Julia
  • Vioque, Jesús
  • López-Miranda, José
  • Estruch, Ramon
  • Bernal-López, M. Rosa
  • Lapetra, José
  • Serra-Majem, Lluís
  • Bueno-Cavanillas, Aurora
  • Tur, Josep A.
  • Martín Sánchez, Vicente
  • Pintó, Xavier
  • Gaforio, José J.
  • Matía-Martín, Pilar
  • Vidal, Josep
  • Vázquez, Clotilde
  • Daimiel, Lidia
  • Ros, Emilio
  • Bes-Rastrollo, Maira
  • Pascual, María
  • Sorlí, Jose V.
  • Goday, Albert
  • Zulet, María Ángeles
  • Moreno-Rodriguez, Anai
  • Carmona González, Francisco Jesús
  • Valls-Enguix, Rafael
  • Janer, Juana M.
  • Garcia-Rios, Antonio
  • Casas, Rosa
  • Gómez-Pérez, Ana M.
  • Santos-Lozano, José Manuel
  • Basterra-Gortari, F. Javier
  • Martínez, María Ángeles
  • Ortega-Azorin, Carolina
  • Bayó, Joan
  • Abete, Itziar
  • Salaverria-Lete, Itziar
  • Ruiz-Canela, Miguel
  • Babio, Nancy
  • Carres, Lourdes
  • Romaguera, Dora
[eng] Non-alcoholic fatty liver disease (NAFLD) includes a spectrum of liver alterations that can result in severe disease and even death. Consumption of ultra-processed foods (UPF) has been associated with obesity and related comorbidities. However, the link between UPF and NAFLD has not been sufficiently assessed. We aimed to investigate the prospective association between UPF consumption and liver health biomarkers. Methods: We followed for 1 year 5867 older participants with overweight/obesity and metabolic syndrome (MetS) from the PREDIMED-Plus trial. A validated 143-item semi-quantitative food frequency questionnaire was used to evaluate consumption of UPF at baseline, 6, and 12 months. The degree of processing for foods and beverages (g/day) was established according to the NOVA classification system. The non-invasive fatty liver index (FLI) and hepatic steatosis index (HSI) were used to evaluate liver health at three points in time. The associations between changes in UPF consumption (percentage of total daily dietary intake (g)) and liver biomarkers were assessed using mixed-effects linear models with repeated measurements. Results: In this cohort, UPF consumption at baseline was 8.19% (SD 6.95%) of total daily dietary intake in grams. In multivariable models, each 10% daily increment in UPF consumption in 1 year was associated with significantly greater FLI (β 1.60 points, 95% CI 1.24;1.96 points) and HSI (0.43, 0.29; 0.57) scores (all p-values < 0.001). These associations persisted statistically significant after adjusting for potential dietary confounders and NAFLD risk factors. Conclusions: A higher UPF consumption was associated with higher levels of NAFLD-related biomarkers in older adults with overweight/obesity and MetS,
RUA. Repositorio Institucional de la Universidad de Alicante
Publication Otros (Other)

Characterization of a novel POLD1 missense founder mutation in a Spanish population

  • Ferrer‐Avargues, Rosario
  • Díez‐Obrero, Virginia
  • Martín‐Tomás, Ester
  • Hernández Illán, Eva
  • Castillejo, María Isabel
  • Codoñer‐Alejos, Alan
  • Barberá, Víctor Manuel
  • Sánchez-Heras, Ana Beatriz
  • Segura, Ángel
  • Juan, María-Jose
  • Tena, Isabel
  • Castillejo, Adela
  • Soto, José Luis
  • Barberá, Víctor Manuel|||/items/014ad996-9d09-431d-8340-f09dde20b90b
  • Soto, José Luis|||/items/23eef350-7ee6-43e1-9743-0b8774d2453f
Background: We identified a new and a recurrent POLD1 mutation associated with predisposition to colorectal cancer (CRC). We characterized the molecular and clinical nature of the potential POLD1 founder mutation in families from Valencia (Spain). Methods: Clinical and molecular data were collected from four independent families known to have a POLD1 Leu474Pro mutation. To establish its founder effect, haplotype construction was performed using 14 flanking POLD1 polymorphic markers. We calculated penetrance estimates and clinical expressivity, globally and stratified by age and sex. Results: We included 32 individuals from the four families: 20 carriers and 12 noncarriers. A common haplotype was identified in these families in a region comprising 2,995 Mb, confirming L474P as the first founder POLD1 mutation identified. Thirteen tumors diagnosed in 10 POLD1 carriers: eight CRC, three endometrial and two other tumors were considered. The median age of cancer onset for POLD1 mutation carriers was 48 years. The observed penetrance was 50% and the cumulative risk at age of 50 years was 30%. Conclusions: The findings of the present study contribute to a better understanding of CRC genetics in the Spanish population. The clinical phenotype for this mutation is similar to that in Lynch syndrome. Future studies using next generation sequencing with large gene panels for any hereditary cancer condition will offer the possibility of detecting POLE/POLD1 mutations in unsuspected clinical situations, demonstrating a more real and unbiased picture of the associated phenotype.
DAU Arxiu Digital de la Universitat Ramon Llull
Publication Artículo científico (JournalArticle)

Therapeutic potential of N-acetylcysteine in acrylamide acute neurotoxicity in adult zebrafish

  • Gómez-Canela, Cristian
  • Faria, Melissa
  • Prats, Eva
  • Hsu, Chuan-Yu
  • Arick, Mark A. II
  • Bedrossiantz, Juliette
  • Orozco, Manuel
  • Garcia-Reyero, Natàlia
  • Ziv, Tamar
  • Ben-Lulu, Shani
  • Admon, Arie
  • Gómez-Oliván, Leobardo Manuel
  • Raldúa, Demetrio
Al 2020 es publica una correcció a Scientific Reports. Vol.10, n.1 (2020), 2247 (https://doi.org/10.1038/s41598-020-58946-z), Two essential key events in acrylamide (ACR) acute neurotoxicity are the formation of adducts with nucleophilic sulfhydryl groups on cysteine residues of selected proteins in the synaptic terminals and the depletion of the glutathione (GSx) stores in neural tissue. The use of N-acetylcysteine (NAC) has been recently proposed as a potential antidote against ACR neurotoxicity, as this chemical is not only a well-known precursor of the reduced form of glutathione (GSH), but also is an scavenger of soft electrophiles such as ACR. In this study, the suitability of 0.3 and 0.75 mM NAC to protect against the neurotoxic effect of 0.75 mM ACR has been tested in vivo in adult zebrafish. NAC provided only a mild to negligible protection against the changes induced by ACR in the motor function, behavior, transcriptome and proteome. The permeability of NAC to cross blood-brain barrier (BBB) was assessed, as well as the ACR-scavenging activity and the gamma-glutamyl-cysteine ligase (γ-GCL) and acylase I activities. The results show that ACR not only depletes GSx levels but also inhibits it synthesis from NAC/cysteine, having a dramatic effect over the glutathione system. Moreover, results indicate a very low NAC uptake to the brain, probably by a combination of low BBB permeability and high deacylation of NAC during the intestinal absorption. These results strongly suggest that the use of NAC is not indicated in ACR acute neurotoxicity treatment.
DAU Arxiu Digital de la Universitat Ramon Llull
Publication Artículo científico (JournalArticle)

Androgenic activation, impairment of the monoaminergic system and altered behavior in zebrafish larvae exposed to environmental concentrations of fenitrothion

  • Faria, Melissa
  • Prats, Eva
  • Rosas Ramírez, Jonathan Ricardo
  • Bellot, Marina
  • Bedrossiantz, Juliette
  • Pagano, Maria
  • Valls, Arnau
  • Gómez-Canela, Cristian
  • Porta, Josep M
  • Mestres, Jordi
  • Garcia-Reyero, Natàlia
  • Faggio, Caterina
  • Gómez-Oliván, Leobardo Manuel
  • Raldúa, Demetrio
Fenitrothion is an organophosphorus insecticide usually found in aquatic ecosystems at concentrations in the range of low ng/L. In this manuscript we show that 24 h exposure to environmental concentrations of fenitrothion, from ng/L to low μg/L, altered basal locomotor activity, visual-motor response and acoustic/vibrational escape response of zebrafish larvae. Furthermore, fenitrothion and expression of gap43a, gfap, atp2b1a, and mbp exhibited a significant non-monotonic concentration-response relationship. Once determined that environmental concentrations of fenitrothion were neurotoxic for zebrafish larvae, a computational analysis identified potential protein targets of this compound. Some of the predictions, including interactions with acetylcholinesterase, monoamine-oxidases and androgen receptor (AR), were experimentally validated. Binding to AR was the most suitable candidate for molecular initiating event, as indicated by both the up-regulation of cyp19a1b and sult2st3 and the non-monotonic relationship found between fenitrothion and the observed responses. Finally, when the integrity of the monoaminergic system was evaluated, altered levels of L-DOPA, DOPAC, HVA and 5-HIAA were found, as well as a significant up-regulation of slc18a2 expression at the lowest concentrations of fenitrothion. These data strongly suggest that concentrations of fenitrothion commonly found in aquatic ecosystems present a significant environmental risk for fish communities., info:eu-repo/semantics/publishedVersion
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC)

  • Sanoja-Flores, L.
  • Flores-Montero, J.
  • Garces, J.J.
  • Paiva, B.
  • Puig, N.
  • Garcia-Mateo, A.
  • Garcia-Sanchez, O.
  • Corral-Mateos, A.
  • Burgos, L.
  • Blanco, E.
  • Hernandez-Martin, J.
  • Pontes, R.
  • Diez-Campelo, M.
  • Millacoy, P.
  • Rodriguez-Otero, P.
  • Prosper, F.
  • Merino, J.
  • Vidriales, M.B.
  • Garcia-Sanz, R.
  • Romero, A.
  • Palomera, L.
  • Rios-Tamayo, R.
  • Perez-Andres, M.
  • Blanco, J.F.
  • Gonzalez, M.
  • van Dongen, J.J.M.
  • Durie, B.
  • Mateos, M.V.
  • San-Miguel, J.
  • Orfao, A.
Here, we investigated for the first time the frequency and number of circulating tumor plasma cells (CTPC) in peripheral blood (PB) of newly diagnosed patients with localized and systemic plasma cell neoplasms (PCN) using next-generation flow cytometry (NGF) and correlated our findings with the distinct diagnostic and prognostic categories of the disease. Overall, 508 samples from 264 newly diagnosed PCN patients, were studied. CTPC were detected in PB of all active multiple myeloma (MM; 100%), and smoldering MM (SMM) patients (100%), and in more than half (59%) monoclonal gammopathy of undetermined significance (MGUS) cases (p < 0.0001); in contrast, CTPC were present in a small fraction of solitary plasmacytoma patients (18%). Higher numbers of CTPC in PB were associated with higher levels of BM infiltration and more adverse prognostic features, together with shorter time to progression from MGUS to MM (p < 0.0001) and a shorter survival in MM patients with active disease requiring treatment (p <= 0.03). In summary, the presence of CTPC in PB as assessed by NGF at diagnosis, emerges as a hallmark of disseminated PCN, higher numbers of PB CTPC being strongly associated with a malignant disease behavior and a poorer outcome of both MGUS and MM.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Membrane-localized magnetic hyperthermia promotes intracellular delivery of cell-impermeant probes

  • Idiago-López, Javier
  • Ferreira, Daniela
  • Asín, Laura
  • Moros, María
  • Armenia, Ilaria
  • Grazú, Valeria
  • Fernandes, Alexandra R.
  • de la Fuente, Jesús M.
  • Baptista, Pedro V.
  • Fratila, Raluca M.
In this work, we report the disruptive use of membrane-localized magnetic hyperthermia to promote the internalization of cell-impermeant probes. Under an alternating magnetic field, magnetic nanoparticles (MNPs) immobilized on the cell membrane via bioorthogonal click chemistry act as nanoheaters and lead to the thermal disruption of the plasma membrane, which can be used for internalization of different types of molecules, such as small fluorescent probes and nucleic acids. Noteworthily, no cell death, oxidative stress and alterations of the cell cycle are detected after the thermal stimulus, although cells are able to sense and respond to the thermal stimulus through the expression of different types of heat shock proteins (HSPs). Finally, we demonstrate the utility of this approach for the transfection of cells with a small interference RNA (siRNA), revealing a similar efficacy to a standard transfection method based on the use of cationic lipid-based reagents (such as Lipofectamine), but with lower cell toxicity. These results open the possibility of developing new procedures for “opening and closing” cellular membranes with minimal disturbance of cellular integrity. This on-demand modification of cell membrane permeability could allow the direct intracellular delivery of biologically relevant (bio)molecules, drugs and nanomaterials, thus overcoming traditional endocytosis pathways and avoiding endosomal entrapment.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients

  • Medina, Alejandro
  • Jimenez, Cristina
  • Sarasquete, Maria Eugenia
  • González, Marcos
  • Chillón, M. Carmen
  • Balanzategui, Ana
  • Gironella Mesa, Mercedes
Investigació genètica; Mieloma, Investigación genética; Mieloma, Genetics research; Myeloma, Multiple myeloma is a heterogeneous disease whose pathogenesis has not been completely elucidated. Although B-cell receptors play a crucial role in myeloma pathogenesis, the impact of clonal immunoglobulin heavy-chain features in the outcome has not been extensively explored. Here we present the characterization of complete heavy-chain gene rearrangements in 413 myeloma patients treated in Spanish trials, including 113 patients characterized by next-generation sequencing. Compared to the normal B-cell repertoire, gene selection was biased in myeloma, with significant overrepresentation of IGHV3, IGHD2 and IGHD3, as well as IGHJ4 gene groups. Hypermutation was high in our patients (median: 8.8%). Interestingly, regarding patients who are not candidates for transplantation, a high hypermutation rate (≥7%) and the use of IGHD2 and IGHD3 groups were associated with improved prognostic features and longer survival rates in the univariate analyses. Multivariate analysis revealed prolonged progression-free survival rates for patients using IGHD2/IGHD3 groups (HR: 0.552, 95% CI: 0.361−0.845, p = 0.006), as well as prolonged overall survival rates for patients with hypermutation ≥7% (HR: 0.291, 95% CI: 0.137−0.618, p = 0.001). Our results provide new insights into the molecular characterization of multiple myeloma, highlighting the need to evaluate some of these clonal rearrangement characteristics as new potential prognostic markers., This work was partially supported by the Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Economy and Competitiveness PI15/01956, CIBERONC-CB16/12/00233, and “Una manera de hacer Europa” (Innocampus; CEI-2010-1-0010)”. M.G.-A., I.P.-C., and C.J. are supported by the Fundación Española de Hematología y Hemoterapia (FEHH, co-funded by Fundación Cris in the latter case), A.M. by the European Social Fund and the Spanish Education Council through the University of Salamanca, and M.E.S. by the ISCIII (CPII18/00028). All Spanish funding is co-sponsored by the European Union FEDER program. The authors wish to thank José Pérez, Alicia Antón, Montserrat Hernández-Ruano, Estrella Arnés, Rebeca Maldonado, Mercedes Jiménez, Alejandra Martín, Isabel Sánchez, Rocío Corral and Francisco Boix (University Hospital of Salamanca, Spain) for their technical support, as well as the Spanish Multiple Myeloma “GEM-PETHEMA” group for providing clinical data. The authors are also very grateful to the patients who participated in this study.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Therapeutic potential of N-acetylcysteine in acrylamide acute neurotoxicity in adult zebrafish

  • Gómez-Canela, Cristian
  • Faria, Melissa
  • Prats, Eva
  • Hsu, Chuan-Yu
  • Arick, Mark A. II
  • Bedrossiantz, Juliette
  • Orozco, Manuel
  • Garcia-Reyero, Natàlia
  • Ziv, Tamar
  • Ben-Lulu, Shani
  • Admon, Arie
  • Gómez-Oliván, Leobardo Manuel
  • Raldúa, Demetrio
Al 2020 es publica una correcció a Scientific Reports. Vol.10, n.1 (2020), 2247 (https://doi.org/10.1038/s41598-020-58946-z), Two essential key events in acrylamide (ACR) acute neurotoxicity are the formation of adducts with nucleophilic sulfhydryl groups on cysteine residues of selected proteins in the synaptic terminals and the depletion of the glutathione (GSx) stores in neural tissue. The use of N-acetylcysteine (NAC) has been recently proposed as a potential antidote against ACR neurotoxicity, as this chemical is not only a well-known precursor of the reduced form of glutathione (GSH), but also is an scavenger of soft electrophiles such as ACR. In this study, the suitability of 0.3 and 0.75 mM NAC to protect against the neurotoxic effect of 0.75 mM ACR has been tested in vivo in adult zebrafish. NAC provided only a mild to negligible protection against the changes induced by ACR in the motor function, behavior, transcriptome and proteome. The permeability of NAC to cross blood-brain barrier (BBB) was assessed, as well as the ACR-scavenging activity and the gamma-glutamyl-cysteine ligase (γ-GCL) and acylase I activities. The results show that ACR not only depletes GSx levels but also inhibits it synthesis from NAC/cysteine, having a dramatic effect over the glutathione system. Moreover, results indicate a very low NAC uptake to the brain, probably by a combination of low BBB permeability and high deacylation of NAC during the intestinal absorption. These results strongly suggest that the use of NAC is not indicated in ACR acute neurotoxicity treatment.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Androgenic activation, impairment of the monoaminergic system and altered behavior in zebrafish larvae exposed to environmental concentrations of fenitrothion

  • Faria, Melissa
  • Prats, Eva
  • Rosas Ramírez, Jonathan Ricardo
  • Bellot, Marina
  • Bedrossiantz, Juliette
  • Pagano, Maria
  • Valls, Arnau
  • Gómez-Canela, Cristian
  • Porta, Josep M
  • Mestres, Jordi
  • Garcia-Reyero, Natàlia
  • Faggio, Caterina
  • Gómez-Oliván, Leobardo Manuel
  • Raldúa, Demetrio
Fenitrothion is an organophosphorus insecticide usually found in aquatic ecosystems at concentrations in the range of low ng/L. In this manuscript we show that 24 h exposure to environmental concentrations of fenitrothion, from ng/L to low μg/L, altered basal locomotor activity, visual-motor response and acoustic/vibrational escape response of zebrafish larvae. Furthermore, fenitrothion and expression of gap43a, gfap, atp2b1a, and mbp exhibited a significant non-monotonic concentration-response relationship. Once determined that environmental concentrations of fenitrothion were neurotoxic for zebrafish larvae, a computational analysis identified potential protein targets of this compound. Some of the predictions, including interactions with acetylcholinesterase, monoamine-oxidases and androgen receptor (AR), were experimentally validated. Binding to AR was the most suitable candidate for molecular initiating event, as indicated by both the up-regulation of cyp19a1b and sult2st3 and the non-monotonic relationship found between fenitrothion and the observed responses. Finally, when the integrity of the monoaminergic system was evaluated, altered levels of L-DOPA, DOPAC, HVA and 5-HIAA were found, as well as a significant up-regulation of slc18a2 expression at the lowest concentrations of fenitrothion. These data strongly suggest that concentrations of fenitrothion commonly found in aquatic ecosystems present a significant environmental risk for fish communities., info:eu-repo/semantics/publishedVersion
Docta Complutense
Publication Artículo científico (JournalArticle)

The Five “Ws” of Frailty Assessment and Chronic Lymphocytic Leukemia: Who, What, Where, Why, and When

  • González Gascón y Marín, Isabel
  • Ballesteros Andrés, Mónica
  • Martínez Flores, Sara
  • Rodríguez Vicente, Ana Eugenia
  • Pérez Carretero, Claudia
  • Quijada Álamo, Miguel
  • Rodríguez Sánchez, Alberto
  • Hernández Rivas, José Ángel
Chronic lymphocytic leukemia (CLL) is a disease of the elderly, but chronological age does not accurately discriminate frailty status at the inter-individual level. Frailty describes a person’s overall resilience. Since CLL is a stressful situation, it is relevant to assess the patient´s degree of frailty, especially before starting antineoplastic treatment. We are in the era of targeted therapies, which have helped to control the disease more effectively and avoid the toxicity of chemo (immuno) therapy. However, these drugs are not free of side effects and other aspects arise that should not be neglected, such as interactions, previous comorbidities, or adherence to treatment, since most of these medications are taken continuously. The challenge we face is to balance the risk of toxicity and efficacy in a personalized way and without forgetting that the most frequent cause of death in CLL is related to the disease. For this purpose, comprehensive geriatric assessment (GA) provides us with the opportunity to evaluate multiple domains that may affect tolerance to treatment and that could be improved with appropriate interventions. In this review, we will analyze the state of the art of GA in CLL through the five Ws.
Docta Complutense
Publication Artículo científico (JournalArticle)

TRAF3 alterations are frequent in del‐3′IGH chronic lymphocytic leukemia patients and define a specific subgroup with adverse clinical features

  • Pérez Carretero, Claudia
  • Hernández Rivas, José Ángel
  • Hernández Sánchez, María
  • González, Teresa
  • Quijada Álamo, Miguel
  • Martín Izquierdo, Marta
  • Santos Mínguez, Sandra
  • Miguel García, Cristina
  • Vidal, María Jesús
  • García de Coca, Alfonso
  • Galende, Josefina
  • Pardal, Emilia
  • Aguilar, Carlos
  • Vargas Pabón, Manuel
  • Dávila, Julio
  • Gascón y Marín, Isabel
  • Hernández Rivas, José Ángel
  • Benito, Rocío
  • Rodríguez Vicente, Ana Eugenia
Interstitial 14q32 deletions involving IGH gene are infrequent events in chronic lymphocytic leukemia (CLL), affecting less than 5% of patients. To date, little is known about their clinical impact and molecular underpinnings, and its mutational landscape is currently unknown. In this work, a total of 871 CLLs were tested for the IGH break-apart probe, and 54 (6.2%) had a 300 kb deletion of 30 IGH (del-30 IGH CLLs), which contributed to a shorter time to first treatment (TFT). The mutational analysis by next-generation sequencing of 317 untreated CLLs (54 del-30 IGH and 263 as the control group) showed high mutational frequencies of NOTCH1 (30%), ATM (20%), genes involved in the RAS signaling pathway (BRAF, KRAS, NRAS, and MAP2K1) (15%), and TRAF3 (13%) within del-30 IGH CLLs. Notably, the incidence of TRAF3 mutations was significantly higher in del-30 IGH CLLs than in the control group (p < .001). Copy number analysis also revealed that TRAF3 loss was highly enriched in CLLs with 14q deletion (p < .001), indicating a complete biallelic inactivation of this gene through deletion and mutation. Interestingly, the presence of mutations in the aforementioned genes negatively refined the prognosis of del-30 IGH CLLs in terms of overall survival (NOTCH1, ATM, and RAS signaling pathway genes) and TFT (TRAF3). Furthermore, TRAF3 biallelic inactivation constituted an independent risk factor for TFT in the entire CLL cohort. Altogether, our work demonstrates the distinct genetic landscape of del-30 IGH CLL with multiple molecular pathways affected, characterized by a TRAF3 biallelic inactivation that contributes to a marked poor outcome in this subgroup of patients.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Isotemporal substitution of inactive time with physical activity and time in bed, cross-sectional associations with cardiometabolic health in the PREDIMED-Plus study

  • Galmes-Panades, Aina M.|||0000-0001-6977-9874
  • Varela-Mato, Veronica
  • Konieczna, Jadwiga|||0000-0002-2947-1338
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Corella, Dolores|||0000-0002-2366-4104
  • Schröder, Helmut|||0000-0003-2231-5081
  • Vioque, Jesús|||0000-0002-2284-148X
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Pintó, Xavier|||0000-0002-2216-2444
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Riquelme-Gallego, Blanca|||0000-0003-3422-7310
  • Gaforio, José J.|||0000-0003-2996-9301
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Micó Pérez, Rafael Manuel|||0000-0002-2575-1236
  • Vidal, Josep|||0000-0002-4564-4518
  • Vázquez, Clotilde
  • Ros, Emilio|||0000-0002-2573-1294
  • Garcia-Arellano, Ana
  • Díaz-López, Andrés|||0000-0002-7500-5629
  • Asensio, Eva Maria|||0000-0003-4558-0988
  • Castañer, Olga|||0000-0003-3169-997X
  • Fiol, Francisca
  • Mira-Castejón, Luis Alfredo
  • Moreno Rodríguez, Anai
  • Benavente-Marín, Juan Carlos
  • Abete, Itziar|||0000-0002-6475-5387
  • Tomaino, Laura
  • Casas, Rosa|||0000-0002-0211-9166
  • Barón López, Francisco Javier|||0000-0001-8707-304X
  • Fernández-García, José C.|||0000-0003-2229-8488
  • Santos-Lozano, José Manuel
  • Galera, Ana
  • Mascaró, Catalina M.
  • Razquín, Cristina|||0000-0003-3480-2645
  • Papandreou, Christopher|||0000-0002-6803-507X
  • Portoles, Olga
  • Pérez-Vega, Karla Alejandra|||0000-0002-7524-2034
  • Fiol-Sala, Miquel
  • Compañ Gabucio, Laura M.|||0000-0001-5324-1535
  • Vaquero-Luna, Jessica
  • Ruiz-Canela, Miguel|||0000-0002-7684-2787
  • Becerra-Tomás, Nerea|||0000-0002-4429-6507
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Romaguera, Dora|||0000-0002-5762-8558
This study explored the association between inactive time and measures of adiposity, clinical parameters, obesity, type 2 diabetes and metabolic syndrome components. It further examined the impact of reallocating inactive time to time in bed, light physical activity (LPA) or moderate-to-vigorous physical activity (MVPA) on cardio-metabolic risk factors, including measures of adiposity and body composition, biochemical parameters and blood pressure in older adults. This is a cross-sectional analysis of baseline data from 2189 Caucasian men and women (age 55-75 years, BMI 27-40 Kg/m 2) from the PREDIMED-Plus study (). All participants had ≥3 components of the metabolic syndrome. Inactive time, physical activity and time in bed were objectively determined using triaxial accelerometers GENEActiv during 7 days (ActivInsights Ltd., Kimbolton, United Kingdom). Multiple adjusted linear and logistic regression models were used. Isotemporal substitution regression modelling was performed to assess the relationship of replacing the amount of time spent in one activity for another, on each outcome, including measures of adiposity and body composition, biochemical parameters and blood pressure in older adults. Inactive time was associated with indicators of obesity and the metabolic syndrome. Reallocating 30 min per day of inactive time to 30 min per day of time in bed was associated with lower BMI, waist circumference and glycated hemoglobin (HbA1c) (all p -values < 0.05). Reallocating 30 min per day of inactive time with 30 min per day of LPA or MVPA was associated with lower BMI, waist circumference, total fat, visceral adipose tissue, HbA1c, glucose, triglycerides, and higher body muscle mass and HDL cholesterol (all p-values < 0.05). Inactive time was associated with a poor cardio-metabolic profile. Isotemporal substitution of inactive time with MVPA and LPA or time in bed could have beneficial impact on cardio-metabolic health.
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

Modulation of the Gut Microbiota by Olive Oil Phenolic Compounds: Implications for Lipid Metabolism, Immune System, and Obesity

  • Farràs Mañé, Marta|||0000-0001-9776-3773
  • Portune, Kevin
  • Arranz, Sara|||0000-0003-2397-5145
  • Frost, Gary
  • Tondo Colomer, Mireia|||0000-0002-0301-9984
  • Blanco Vaca, Francisco|||0000-0001-7380-5385
  • Martinez Gili, Laura|||0000-0001-5271-9672
There is extensive information of the beneficial effects of virgin olive oil (VOO), especially on cardiovascular diseases. Some VOO healthy properties have been attributed to their phenolic-compounds (PCs). The aim of this review is to present updated data on the effects of olive oil (OO) PCs on the gut microbiota, lipid metabolism, immune system, and obesity, as well as on the crosstalk among them. We summarize experiments and clinical trials which assessed the specific effects of the olive oil phenolic-compounds (OOPCs) without the synergy with OO-fats. Several studies have demonstrated that OOPC consumption increases Bacteroidetes and/or reduces the Firmicutes/Bacteroidetes ratio, which have both been related to atheroprotection. OOPCs also increase certain beneficial bacteria and gut-bacteria diversity which can be therapeutic for lipid-immune disorders and obesity. Furthermore, some of the mechanisms implicated in the crosstalk between OOPCs and these disorders include antimicrobial-activity, cholesterol microbial metabolism, and metabolites produced by bacteria. Specifically, OOPCs modulate short-chain fatty-acids produced by gut-microbiota, which can affect cholesterol metabolism and the immune system, and may play a role in weight gain through promoting satiety. Since data in humans are scarce, there is a necessity for more clinical trials designed to assess the specific role of the OOPCs in this crosstalk.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma

  • Medina, Alejandro|||0000-0001-5609-2969
  • Puig, Noemí|||0000-0001-7535-3861
  • Flores-Montero, Juan|||0000-0002-1119-4387
  • Jimenez, Cristina
  • Sarasquete, M. Eugenia|||0000-0001-7335-3657
  • García-Álvarez, María|||0000-0001-8864-1168
  • Prieto-Conde, Isabel|||0000-0002-2510-8355
  • Chillon, Carmen
  • Alcoceba, Miguel|||0000-0002-3819-4846
  • Gutierrez, Norma C.
  • Oriol, Albert|||0000-0001-6804-2221
  • Rosinol, Laura
  • Bladé Creixenti, Juan|||0000-0002-4563-3405
  • Gironella, Mercedes|||0000-0002-8106-8909
  • Hernandez, Miguel T.
  • Gonzalez-Calle, Verónica
  • Cedena, María Teresa|||0000-0001-5851-3720
  • Paiva, Bruno|||0000-0003-1977-3815
  • San Miguel, Jesús|||0000-0002-9183-4857
  • Lahuerta, J. J.|||0000-0002-3393-9570
  • Mateos, M. V.|||0000-0003-2390-1218
  • Martínez-López, Joaquín|||0000-0001-7908-0063
  • Orfao, Alberto|||0000-0002-0007-7230
  • González, Marcos
  • García-Sanz, Ramón|||0000-0003-4120-2787
Detecting persistent minimal residual disease (MRD) allows the identification of patients with an increased risk of relapse and death. In this study, we have evaluated MRD 3 months after transplantation in 106 myeloma patients using a commercial next-generation sequencing (NGS) strategy (LymphoTrack®), and compared the results with next-generation flow (NGF, EuroFlow). The use of different marrow pulls and the need of concentrating samples for NGS biased the applicability for MRD evaluation and favored NGF. Despite that, correlation between NGS and NGF was high (R = 0.905). The 3-year progression-free survival (PFS) rates by NGS and NGF were longer for undetectable vs. positive patients (NGS: 88.7% vs. 56.6%; NGF: 91.4% vs. 50%; p < 0.001 for both comparisons), which resulted in a 3-year overall survival (OS) advantage (NGS: 96.2% vs. 77.3%; NGF: 96.6% vs. 74.9%, p < 0.01 for both comparisons). In the Cox regression model, NGS and NGF negativity had similar results but favoring the latter in PFS (HR: 0.20, 95% CI: 0.09-0.45, p < 0.001) and OS (HR: 0.21, 95% CI: 0.06-0.75, p = 0.02). All these results reinforce the role of MRD detection by different strategies in patient prognosis and highlight the use of MRD as an endpoint for multiple myeloma treatment.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Trimethylamine N -Oxide, A Link among Diet, Gut Microbiota, Gene Regulation of Liver and Intestine Cholesterol Homeostasis and HDL Function

  • Canyelles, Marina|||0000-0002-0278-5337
  • Tondo Colomer, Mireia|||0000-0002-0301-9984
  • Cedó, Lídia|||0000-0003-4354-3411
  • Farràs Mañé, Marta|||0000-0001-9776-3773
  • Escolà-Gil, Joan Carles|||0000-0001-9021-2485
  • Blanco Vaca, Francisco|||0000-0001-7380-5385
Recent evidence, including massive gene-expression analysis and a wide-variety of other multi-omics approaches, demonstrates an interplay between gut microbiota and the regulation of plasma lipids. Gut microbial metabolism of choline and -carnitine results in the formation of trimethylamine (TMA) and concomitant conversion into trimethylamine- N -oxide (TMAO) by liver flavin monooxygenase 3 (FMO3). The plasma level of TMAO is determined by the genetic variation, diet and composition of gut microbiota. Multiple studies have demonstrated an association between TMAO plasma levels and the risk of atherothrombotic cardiovascular disease (CVD). We aimed to review the molecular pathways by which TMAO production and FMO3 exert their proatherogenic effects. TMAO may promote foam cell formation by upregulating macrophage scavenger receptors, deregulating enterohepatic cholesterol and bile acid metabolism and impairing macrophage reverse cholesterol transport (RCT). Furthermore, FMO3 may promote dyslipidemia by regulating multiple genes involved in hepatic lipogenesis and gluconeogenesis. FMO3 also impairs multiple aspects of cholesterol homeostasis, including transintestinal cholesterol export and macrophage-specific RCT. At least part of these FMO3-mediated effects on lipid metabolism and atherogenesis seem to be independent of the TMA/TMAO formation. Overall, these findings have the potential to open a new era for the therapeutic manipulation of the gut microbiota to improve CVD risk.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Leisure-time physical activity, sedentary behaviors, sleep, and cardiometabolic risk factors at baseline in the PREDIMED-PLUS intervention trial, A cross-sectional analysis

  • Rosique-Esteban, Nuria
  • Díaz-López, Andrés|||0000-0002-7500-5629
  • Martínez-González, Miguel A.
  • Corella, Dolores|||0000-0002-2366-4104
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Romaguera, Dora|||0000-0002-5762-8558
  • Vioque, Jesús|||0000-0002-2284-148X
  • Arós, Fernando
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Tinahones, Francisco
  • Estruch, Ramón|||0000-0003-1260-4445
  • Fernández-García, José C.|||0000-0003-2229-8488
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Pintó, Xavier|||0000-0002-2216-2444
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Bueno-Cavanillas, Aurora|||0000-0002-0649-3016
  • Vidal, Josep|||0000-0002-4564-4518
  • Delgado-Rodríguez, Miguel
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Vázquez, Clotilde
  • Rubio Herrera, Miguel Ángel
  • Ros, Emilio|||0000-0002-2573-1294
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
Limited data exists on the interrelationships between physical activity (PA), sedentary behaviors and sleep concerning cardiometabolic risk factors in aged adults at high cardiovascular disease risk. Our aim was to examine independent and joint associations between time spent in leisure-time PA, sedentary behaviors and sleep on the prevalence of obesity, type 2 diabetes (T2D) and components of the metabolic syndrome (MetS) in Mediterranean individuals at high cardiovascular risk. Cross-sectional analyses were performed on baseline data from 5776 Spanish adults (aged 55-75y in men; 60-75y in women) with overweight/obesity and MetS, from October 2013 to October 2016, in the PREDIMED-PLUS trial. Employing multivariable-adjusted Cox regression with robust variance and constant time (given the cross-sectional design), higher prevalence of obesity, T2D and abdominal obesity as component of the MetS were associated with greater time in TV-viewing (Relative Risk, RR: 1.02, 95%CI: 1.01, 1.03; RR:1.04, 95%CI: 1.02, 1.06 and RR: 1.01 95%CI: 1.00, 1.02; respectively, all P <.01). Conversely, greater time in moderate-vigorous PA (MVPA) was associated with lower prevalence of obesity, T2D, abdominal obesity and low HDL-cholesterol (RR: 0.95, 95%CI: 0.93, 0.97; RR: 0.94, 95%CI: 0.89, 0.99; RR: 0.97, 95%CI: 0.96, 0.98; and RR: 0.95, 95%CI: 0.91, 0.99, respectively, all P <.05). For these outcomes, theoretically substituting 1-h/day of MVPA for 1-h/day TV-viewing was also significantly associated with lower prevalence (RR 0.91 to 0.97, all P <.05). Similar lower RR in these outcomes was observed when substituting 1-h/day of MVPA for 1-h/day of sleeping. Longer time watching TV and not meeting MVPA recommendations were jointly associated with higher RR of the prevalence of obesity and T2D. We concluded that, in senior individuals at high cardiovascular risk, greater time spent on MVPA and fewer on sedentary behaviors was inversely associated with prevalence of obesity, T2D, and some of the components of MetS.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Screening Physical Activity in Family Practice, Validity of the Spanish Version of a Brief Physical Activity Questionnaire

  • Puig Ribera, Anna|||0000-0003-2910-1924
  • Martín-Cantera, Carlos|||0000-0003-0656-8126
  • Puigdomènech, Elisa
  • Real, Jordi|||0000-0002-5979-8948
  • Romaguera, Montserrat
  • Magdalena-Belio, José Félix
  • Recio Rodríguez, José I.|||0000-0002-3772-8746
  • Rodríguez-Martín, Beatriz
  • Arietaleanizbeaskoa, Maria Soledad|||0000-0001-8747-6789
  • Repiso-Gento, Irene
  • Garcia-Ortiz, Luis|||0000-0001-6555-8302
The use of brief screening tools to identify inactive patients is essential to improve the efficiency of primary care-based physical activity (PA) programs. However, the current employment of short PA questionnaires within the Spanish primary care pathway is unclear. This study evaluated the validity of the Spanish version of a Brief Physical Activity Assessment Tool (SBPAAT). A validation study was carried out within the EVIDENT project. A convenience sample of patients (n = 1,184; age 58.9±13.7 years; 60.5% female) completed the SBPAAT and the 7-day Physical Activity Recall (7DPAR) and, in addition, wore an accelerometer (ActiGraph GT3X) for seven consecutive days. Validity was evaluated by measuring agreement, Kappa correlation coefficients, sensitivity and specificity in achieving current PA recommendations with the 7DPAR. Pearson correlation coefficients with the number of daily minutes engaged in moderate and vigorous intensity PA according to the accelerometer were also assessed. Comparison with accelerometer counts, daily minutes engaged in sedentary, light, moderate, and vigorous intensity PA, total daily kilocalories, and total PA and leisure time expenditure (METs-hour-week) between the sufficiently and insufficiently active groups identified by SBPAAT were reported. The SBPAAT identified 41.3% sufficiently active (n = 489) and 58.7% insufficiently active (n = 695) patients; it showed moderate validity (k = 0.454, 95% CI: 0.402-0.505) and a specificity and sensitivity of 74.3% and 74.6%, respectively. Validity was fair for identifying daily minutes engaged in moderate (r = 0.215, 95% CI:0.156 to 0.272) and vigorous PA (r = 0.282, 95% CI:0.165 to 0.391). Insufficiently active patients according to the SBPAAT significantly reported fewer counts/minute (-22%), fewer minutes/day of moderate (-11.38) and vigorous PA (-2.69), spent fewer total kilocalories/day (-753), and reported a lower energy cost (METs-hour-week) of physical activities globally (-26.82) and during leisure time (-19.62). The SBPAAT is a valid tool to identify Spanish-speaking patients who are insufficiently active to achieve health benefits.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Consumption of caffeinated beverages and kidney function decline in an elderly Mediterranean population with metabolic syndrome

  • Díaz-López, Andrés|||0000-0002-7500-5629
  • Paz-Graniel, Indira
  • Ruiz, Verónica
  • Toledo, Estefania|||0000-0002-6263-4434
  • Becerra-Tomás, Nerea|||0000-0002-4429-6507
  • Corella, Dolores|||0000-0002-2366-4104
  • Castañer, Olga|||0000-0003-3169-997X
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • López-Miranda, José|||0000-0002-8844-0718
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Bueno-Cavanillas, Aurora|||0000-0002-0649-3016
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Martín, Vicente|||0000-0003-0552-2804
  • Pintó, Xavier|||0000-0002-2216-2444
  • Delgado-Rodríguez, Miguel
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Vázquez, Clotilde
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Villa, Tania Fernandez
  • Ros, Emilio|||0000-0002-2573-1294
  • Eguaras, Sonia
  • Babio, Nancy|||0000-0003-3527-5277
  • Sorlí, José V.|||0000-0002-0130-2006
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Abete, Itziar|||0000-0002-6475-5387
  • Tojal-Sierra, Lucas|||0000-0001-5338-9601
  • Barón López, Francisco Javier|||0000-0001-8707-304X
  • Torres-Collado, Laura
  • Morey, Marga
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Casas, Rosa|||0000-0002-0211-9166
  • Bernal-Lopez, María Rosa|||0000-0002-0238-0890
  • Santos-Lozano, José Manuel
  • Navarro, Adela
  • Gonzalez, Jose I.
  • Zomeño, María Dolores|||0000-0003-1280-7680
  • Zulet, M. Angeles|||0000-0002-3926-0892
  • Luna, Jessica Vaquero
  • Ramallal, Raul
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
It remains unclear whether caffeinated beverages could have deleterious renal effects in elderly population with underlying comorbid conditions. We investigated the associations between coffee, tea, or caffeine intake and 1-year changes in glomerular filtration rate (eGFR) in a large Spanish cohort of overweight/obese elderly with metabolic syndrome (MetS). This prospective analysis includes 5851 overweight/obese adults (55-75 years) with MetS from the PREDIMED-Plus study. We assessed coffee, tea, and caffeine consumption from a validated food-frequency questionnaire and creatinine-based eGFR using the Chronic Kidney Disease Epidemiology Collaboration equation. Multivariate-adjusted regression models were applied to test associations between baseline coffee, tea, or caffeine intake and 1-year eGFR changes. Caffeinated coffee (.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Adopting a High-Polyphenolic Diet Is Associated with an Improved Glucose Profile, Prospective Analysis within the PREDIMED-Plus Trial

  • Tresserra-Rimbau, Anna|||0000-0002-7022-9041
  • Castro Barquero, Sara|||0000-0002-6876-5443
  • Becerra-Tomás, Nerea|||0000-0002-4429-6507
  • Babio, Nancy|||0000-0003-3527-5277
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Corella, Dolores|||0000-0002-2366-4104
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Romaguera, Dora|||0000-0002-5762-8558
  • Vioque, Jesús|||0000-0002-2284-148X
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Pintó, Xavier|||0000-0002-2216-2444
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • López-Miranda, José|||0000-0002-8844-0718
  • Cano-Ibáñez, Naomi|||0000-0002-3640-5486
  • Delgado-Rodríguez, Miguel
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Martín, Vicente|||0000-0003-0552-2804
  • Vidal, Josep|||0000-0002-4564-4518
  • Vázquez, Clotilde
  • Ros, Emilio|||0000-0002-2573-1294
  • Basterra Gortari, Francisco Javier|||0000-0002-1506-2349
  • Fernández de la Puente, María
  • Asensio, Eva Maria|||0000-0003-4558-0988
  • Castañer, Olga|||0000-0003-3169-997X
  • Bullón-Vela, Vanessa|||0000-0003-3639-821X
  • Tojal-Sierra, Lucas|||0000-0001-5338-9601
  • Gómez-Gracia, Enrique
  • Cases-Pérez, Eugenio
  • Konieczna, Jadwiga|||0000-0002-2947-1338
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Casañas-Quintana, Tamara
  • Bernal-Lopez, María Rosa|||0000-0002-0238-0890
  • Santos-Lozano, José Manuel
  • Esteve-Luque, Virginia|||0000-0002-7631-8301
  • Bouzas, Cristina|||0000-0002-1407-8461
  • Vázquez-Ruiz, Zenaida|||0000-0002-6828-9627
  • Palau Galindo, Antoni|||0000-0002-2512-0872
  • Barragán, Rocío|||0000-0001-8072-3791
  • López Grau, Mercè
  • Razquín, Cristina|||0000-0003-3480-2645
  • Goicolea-Güemez, Leire
  • Toledo, Estefania|||0000-0002-6263-4434
  • Vergaz, Manel Vila
  • Lamuela-Raventós, Rosa M.|||0000-0002-1287-4560
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
Previous studies suggested that dietary polyphenols could reduce the incidence and complications of type-2 diabetes (T2D); although the evidence is still limited and inconsistent. This work analyzes whether changing to a diet with a higher polyphenolic content is associated with an improved glucose profile. At baseline, and at 1 year of follow-up visits, 5921 participants (mean age 65.0 ± 4.9, 48.2% women) who had overweight/obesity and metabolic syndrome filled out a validated 143-item semi-quantitative food frequency questionnaire (FFQ), from which polyphenol intakes were calculated. Energy-adjusted total polyphenols and subclasses were categorized in tertiles of changes. Linear mixed-effect models with random intercepts (the recruitment centers) were used to assess associations between changes in polyphenol subclasses intake and 1-year plasma glucose or glycosylated hemoglobin (HbA1c) levels. Increments in total polyphenol intake and some classes were inversely associated with better glucose levels and HbA1c after one year of follow-up. These associations were modified when the analyses were run considering diabetes status separately. To our knowledge, this is the first study to assess the relationship between changes in the intake of all polyphenolic groups and T2D-related parameters in a senior population with T2D or at high-risk of developing T2D.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Inflammatory potential of diet and bone mineral density in a senior Mediterranean population, a cross-sectional analysis of PREDIMED-Plus study

  • García-Gavilán, Jesús F.
  • Paz-Graniel, Indira
  • Babio, Nancy|||0000-0003-3527-5277
  • Romaguera, Dora|||0000-0002-5762-8558
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Martín, Vicente|||0000-0003-0552-2804
  • Martínez, María Ángeles
  • Konieczna, Jadwiga|||0000-0002-2947-1338
  • Ruiz-Canela, Miguel|||0000-0002-7684-2787
  • de Paz, José Antonio|||0000-0002-4389-1777
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Bulló, Mònica|||0000-0002-0218-7046
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
Inflammation could play a key role in tissue damage and bone metabolism. The modified dietary inflammatory score (M-DIS) is a validated tool to estimate the inflammatory potential of the diet. In the present study, we evaluate the associations between the M-DIS and bone mineral density (BMD) in a senior Mediterranean population with overweight/obesity and metabolic syndrome. Baseline cross-sectional association between the M-DIS and bone mineral density was assessed in 1134 participants of the multicenter PREDIMED-Plus trial (aged 55-75 with overweight/obesity and metabolic syndrome). BMD was measured using Dual-energy X-ray Absorptiometry scans and participants answered a food frequency questionnaire to determine the M-DIS. BMD was categorized as low BMD when T score was equal or lower than -1 and normal BMD in another case. Associations between BMD and M-DIS were evaluated by using linear and logistic regressions adjusted by other co-variates. Participants in the top tertile of the M-DIS had a lower BMD at total femur [β (95% CI) - 0.02 (- 0.04, - 0.01)], trochanter areas [β (95% CI) - 0.03 (- 0.05, - 0.01)] and lumbar spine area [β (95% CI) - 0.03 (- 0.07, 0.01)] (but in the last case, measures were less precise and hence not statistically significant) compared to those in the lower M-DIS tertile. Multiple logistic regression analyses showed that the odds of the total femur and femoral trochanter osteopenia/osteoporosis were higher in participants in the top tertile compared to those in the lowest tertile of M-DIS [OR (95% CI) 1.71 (1.12, 2.64), P for trend 0.015; 2.02 (1.29, 3.21), P for trend 0.002, respectively]. A high pro-inflammatory diet, measured by the M-DIS, is associated with lower BMD in a senior Mediterranean population with metabolic syndrome. The online version contains supplementary material available at 10.1007/s00394-021-02751-5.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Does Consumption of Ultra-Processed Foods Matter for Liver Health? Prospective Analysis among Older Adults with Metabolic Syndrome

  • Konieczna, Jadwiga|||0000-0002-2947-1338
  • Fiol-Sala, Miquel
  • Colom, Antoni|||0000-0001-5041-0778
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Corella, Dolores|||0000-0002-2366-4104
  • Soria-Florido, María Trinidad|||0000-0002-5625-9033
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • López-Miranda, José|||0000-0002-8844-0718
  • Estruch, Ramón|||0000-0003-1260-4445
  • Bernal-Lopez, María Rosa|||0000-0002-0238-0890
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Bueno-Cavanillas, Aurora|||0000-0002-0649-3016
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Martín, Vicente|||0000-0003-0552-2804
  • Pintó, Xavier|||0000-0002-2216-2444
  • Gaforio, José J.|||0000-0003-2996-9301
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Vázquez, Clotilde
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Ros, Emilio|||0000-0002-2573-1294
  • Bes-Rastrollo, Maira|||0000-0002-9139-4206
  • Pascual, María
  • Sorlí, José V.|||0000-0002-0130-2006
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Zulet, M. Angeles|||0000-0002-3926-0892
  • Moreno-Rodriguez, Anai
  • Carmona González, Francisco Jesús
  • Valls-Enguix, Rafael
  • Janer, Juana M.
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Casas, Rosa|||0000-0002-0211-9166
  • Gómez Pérez, Ana María|||0000-0002-2874-5894
  • Santos-Lozano, José Manuel
  • Basterra Gortari, Francisco Javier|||0000-0002-1506-2349
  • Martínez, María Ángeles
  • Ortega-Azorín, Carolina|||0000-0001-6719-9358
  • Bayó, Joan
  • Abete, Itziar|||0000-0002-6475-5387
  • Salaverria-Lete, Itziar|||0000-0002-9504-4668
  • Ruiz-Canela, Miguel|||0000-0002-7684-2787
  • Babio, Nancy|||0000-0003-3527-5277
  • Carres, Lourdes
  • Romaguera, Dora|||0000-0002-5762-8558
Non-alcoholic fatty liver disease (NAFLD) includes a spectrum of liver alterations that can result in severe disease and even death. Consumption of ultra-processed foods (UPF) has been associated with obesity and related comorbidities. However, the link between UPF and NAFLD has not been sufficiently assessed. We aimed to investigate the prospective association between UPF consumption and liver health biomarkers. Methods: We followed for 1 year 5867 older participants with overweight/obesity and metabolic syndrome (MetS) from the PREDIMED-Plus trial. A validated 143-item semi-quantitative food frequency questionnaire was used to evaluate consumption of UPF at baseline, 6, and 12 months. The degree of processing for foods and beverages (g/day) was established according to the NOVA classification system. The non-invasive fatty liver index (FLI) and hepatic steatosis index (HSI) were used to evaluate liver health at three points in time. The associations between changes in UPF consumption (percentage of total daily dietary intake (g)) and liver biomarkers were assessed using mixed-effects linear models with repeated measurements. Results: In this cohort, UPF consumption at baseline was 8.19% (SD 6.95%) of total daily dietary intake in grams. In multivariable models, each 10% daily increment in UPF consumption in 1 year was associated with significantly greater FLI (β 1.60 points, 95% CI 1.24;1.96 points) and HSI (0.43, 0.29; 0.57) scores (all p -values < 0.001). These associations persisted statistically significant after adjusting for potential dietary confounders and NAFLD risk factors. Conclusions: A higher UPF consumption was associated with higher levels of NAFLD-related biomarkers in older adults with overweight/obesity and MetS.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Impulsive Personality Traits Predicted Weight Loss in Individuals with Type 2 Diabetes after 3 Years of Lifestyle Interventions

  • Testa, Giulia|||0000-0003-4200-8062
  • Camacho-Barcia, Lucía|||0000-0002-5989-936X
  • Gómez-Martínez, Carlos|||0000-0002-3077-6702
  • Mora-Maltas, Bernat|||0000-0002-4142-3208
  • Torre, Rafael de la|||0000-0002-6765-1866
  • Pintó, Xavier|||0000-0002-2216-2444
  • Corella, Dolores|||0000-0002-2366-4104
  • Granero, Roser|||0000-0001-6308-3198
  • Cuenca-Royo, Aida|||0000-0001-8551-5457
  • Jiménez Murcia, Susana|||0000-0002-3596-8033
  • Babio, Nancy|||0000-0003-3527-5277
  • Fernández-Carrión, Rebeca
  • Esteve-Luque, Virginia|||0000-0002-7631-8301
  • Forcano, Laura|||0000-0002-8478-1451
  • Ni, Jiaqi
  • Malcampo Manrúbia, Mireia|||0000-0002-1916-4537
  • De las Heras-Delgado, Sara|||0000-0002-3439-5712
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
Impulsivity has been associated with type 2 diabetes (T2D) and may negatively impact its management. This study aimed to investigate impulsive personality traits in an older adult population with T2D and their predicting role in long-term weight control and glycemic management, through glycated hemoglobin (HbA), following 3 years of intervention with a Mediterranean diet. The Impulsive Behavior Scale (UPPS-P) was administered as a measure of impulsive traits at baseline. Results showed higher total baseline scores of UPPS-P, and higher positive urgency in individuals with T2D, compared with those without T2D. The regression analysis in patients with T2D showed that sensation seeking and lack of perseverance predicted weight loss at follow-up. By contrast, impulsive traits did not predict follow-up levels of HbA. In conclusion, the present findings suggest that higher impulsive traits in individuals with T2D seem to affect long-term weight control, but not glycemic control.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A gene expression assay based on chronic lymphocytic leukemia activation in the microenvironment to predict progression

  • Abrisqueta, Pau|||0000-0001-9625-7422
  • Medina, Daniel
  • Villacampa Javierre, Guillermo|||0000-0003-4868-6585
  • Lu, Junyan
  • Alcoceba, Miguel|||0000-0002-3819-4846
  • Carabia, Júlia
  • Boix, Joan
  • Tazón-Vega, Barbara
  • Iacoboni, Gloria|||0000-0003-0805-9288
  • Bobillo, Sabela|||0000-0001-7381-680X
  • Marín-Niebla, Ana|||0000-0002-7592-6815
  • González, Marcos
  • Zenz, Thorsten|||0000-0001-7890-9845
  • Crespo Maull, Marta|||0000-0002-7732-7808
  • Bosch Albareda, Francesc|||0000-0001-9241-2886
Several gene expression profiles with a strong correlation with patient outcomes have been previously described in chronic lymphocytic leukemia (CLL), although their applicability as biomarkers in clinical practice has been particularly limited. Here we describe the training and validation of a gene expression signature for predicting early progression in patients with CLL based on the analysis of 200 genes related to microenvironment signaling on the NanoString platform. In the training cohort (n = 154), the CLL15 assay containing a 15-gene signature was associated with the time to first treatment (TtFT) (hazard ratio [HR], 2.83; 95% CI, 2.17-3.68; P <.001). The prognostic value of the CLL15 score (HR, 1.71; 95% CI, 1.15-2.52; P =.007) was further confirmed in an external independent validation cohort (n = 112). Notably, the CLL15 score improved the prognostic capacity over IGHV mutational status and the International Prognostic Score for asymptomatic early-stage (IPS-E) CLL. In multivariate analysis, the CLL15 score (HR, 1.83; 95% CI, 1.32-2.56; P <.001) and the IPS-E CLL (HR, 2.23; 95% CI, 1.59-3.12; P <.001) were independently associated with TtFT. The newly developed and validated CLL15 assay successfully translated previous gene signatures such as the microenvironment signaling into a new gene expression-based assay with prognostic implications in CLL.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Mass spectrometry vs immunofixation for treatment monitoring in multiple myeloma

  • Puig, Noemí|||0000-0001-7535-3861
  • Contreras, María Teresa|||0000-0002-2264-7791
  • Agulló, Cristina
  • Martínez-López, Joaquín|||0000-0001-7908-0063
  • Oriol, Albert|||0000-0001-6804-2221
  • Blanchard, María Jesús
  • Ríos-Tamayo, Rafael|||0000-0001-8193-1402
  • Martín Sánchez, Jesús|||0000-0003-4250-4824
  • Iñigo Rodríguez, María Belén
  • Sureda, Anna|||0000-0002-1238-6970
  • Hernández, Miguel Teodoro|||0000-0002-6576-7881
  • de la Rubia, Javier|||0000-0002-8354-768X
  • González-Calle, Verónica|||0000-0002-5493-6707
  • Krsnik, Isabel|||0000-0002-2912-5072
  • Cabañas Perianes, Valentín|||0000-0002-6248-2549
  • Palomera, Luis|||0000-0003-0359-7191
  • Moraleda, José María|||0000-0001-9080-1466
  • Bargay, Joan|||0000-0002-6739-3916
  • Cedena, María Teresa|||0000-0001-5851-3720
  • Paiva, Bruno|||0000-0003-1977-3815
  • Rosiñol, Laura|||0000-0002-2534-9239
  • Bladé Creixenti, Juan|||0000-0002-4563-3405
  • San Miguel, Jesús|||0000-0002-9183-4857
  • Lahuerta, J. J.|||0000-0002-3393-9570
  • Mateos, M. V.|||0000-0003-2390-1218
Monitoring of the monoclonal protein (M-protein) by electrophoresis and/or immunofixation (IFE) has long been used to assess treatment response in multiple myeloma (MM). However, with the use of highly effective therapies, the M-protein becomes frequently undetectable, and more sensitive methods had to be explored. We applied IFE and mass spectrometry (EXENT&FLC-MS) in serum samples from newly diagnosed MM patients enrolled in the PETHEMA/GEM2012MENOS65 obtained at baseline (n 5 223), and after induction (n 5 183), autologous stem cell transplantation (n 5 173), and consolidation (n 5 173). At baseline, the isotypes identified with both methods fully matched in 82.1% of samples; in the rest but 2 cases, EXENT&FLC-MS provided additional information to IFE with regards to the M-protein(s). Overall, the results of EXENT&FLC-MS and IFE were concordant in.80% of cases, being most discordances due to EXENT&FLC-MS but IFE cases. After consolidation, IFE was not able to discriminate 2 cohorts with different median progression-free survival (PFS), but EXENT&FLC-MS did so; furthermore, among IFE patients, EXENT&FLC-MS identified 2 groups with significantly different median PFS (P 5.0008). In conclusion, compared with IFE, EXENT&FLC-MS is more sensitive to detect the M-protein of patients with MM, both at baseline and during treatment, and provides a more accurate prediction of patients' outcome. This trial was registered at www.clinicaltrials.gov as #NCT01916252.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Carbon dioxide (CO) emissions and adherence to Mediterranean diet in an adult population, the Mediterranean diet index as a pollution level index

  • García, Silvia
  • Bouzas, Cristina|||0000-0002-1407-8461
  • Mateos, David
  • Pastor, Rosario
  • Álvarez, Laura
  • Rubín, María
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Corella, Dolores|||0000-0002-2366-4104
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • Lopez-Miranda, José
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Riquelme-Gallego, Blanca|||0000-0003-3422-7310
  • Pintó, Xavier|||0000-0002-2216-2444
  • Gaforio, José J.|||0000-0003-2996-9301
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Ros, Emilio|||0000-0002-2573-1294
  • Bes-Rastrollo, Maira|||0000-0002-9139-4206
  • Guillem-Saiz, Patricia
  • Nishi, Stephanie
  • Cabanes, Robert
  • Abete, Itziar|||0000-0002-6475-5387
  • Goicolea-Güemez, Leire
  • Gómez-Gracia, Enrique
  • Signes-Pastor, Antonio José
  • Colom, Antoni|||0000-0001-5041-0778
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Castro Barquero, Sara|||0000-0002-6876-5443
  • Fernández-García, José C.|||0000-0003-2229-8488
  • Santos-Lozano, José Manuel
  • Vázquez, Zenaida
  • Sorlí, José V.|||0000-0002-0130-2006
  • Pascual, Maria
  • Castañer, Olga|||0000-0003-3169-997X
  • Zulet, M. Angeles|||0000-0002-3926-0892
  • Vaquero-Luna, Jessica
  • Basterra Gortari, Francisco Javier|||0000-0002-1506-2349
  • Babio, Nancy|||0000-0003-3527-5277
  • Ciurana, Ramon
  • Martín, Vicente|||0000-0003-0552-2804
  • Tur, Josep Antonio|||0000-0002-6940-0761
Research related to sustainable diets is is highly relevant to provide better understanding of the impact of dietary intake on the health and the environment. To assess the association between the adherence to an energy-restricted Mediterranean diet and the amount of CO emitted in an older adult population. Using a cross-sectional design, the association between the adherence to an energy-reduced Mediterranean Diet (erMedDiet) score and dietary CO emissions in 6646 participants was assessed. Food intake and adherence to the erMedDiet was assessed using validated food frequency questionnaire and 17-item Mediterranean questionnaire. Sociodemographic characteristics were documented. Environmental impact was calculated through greenhouse gas emissions estimations, specifically CO emissions of each participant diet per day, using a European database. Participants were distributed in quartiles according to their estimated CO emissions expressed in kg/day: Q1 (≤2.01 kg CO), Q2 (2.02-2.34 kg CO), Q3 (2.35-2.79 kg CO) and Q4 (≥2.80 kg CO). More men than women induced higher dietary levels of CO emissions. Participants reporting higher consumption of vegetables, fruits, legumes, nuts, whole cereals, preferring white meat, and having less consumption of red meat were mostly emitting less kg of CO through diet. Participants with higher adherence to the Mediterranean Diet showed lower odds for dietary CO emissions: Q2 (OR 0.87; 95%CI: 0.76-1.00), Q3 (OR 0.69; 95%CI: 0.69-0.79) and Q4 (OR 0.48; 95%CI: 0.42-0.55) vs Q1 (reference). The Mediterranean diet can be environmentally protective since the higher the adherence to the Mediterranean diet, the lower total dietary CO emissions. Mediterranean Diet index may be used as a pollution level index.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Impact of Phenol-Enriched Olive Oils on Serum Metabonome and Its Relationship with Cardiometabolic Parameters, A Randomized, Double-Blind, Cross-Over, Controlled Trial

  • Farràs Mañé, Marta|||0000-0001-9776-3773
  • Swann, Jonathan Richard
  • Rowland, Ian
  • Rubió, Laura
  • Subirana, Isaac|||0000-0003-1676-0197
  • Catalán, Úrsula
  • Motilva, Maria-José|||0000-0001-8985-7737
  • Solà, Rosa|||0000-0002-8359-235X
  • Covas Planells, Maria Isabel
  • Blanco Vaca, Francisco|||0000-0001-7380-5385
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Mayneris-Perxachs, Jordi|||0000-0003-3788-3815
Phenol-rich foods consumption such as virgin olive oil (VOO) has been shown to have beneficial effects on cardiovascular diseases. The broader biochemical impact of VOO and phenol-enriched OOs remains, however, unclear. A randomized, double-blind, cross-over, controlled trial was performed with thirty-three hypercholesterolemic individuals who ingested for 3-weeks (25 mL/day): (1) an OO enriched with its own olive oil phenolic compounds (PCs) (500 ppm; FOO); (2) an OO enriched with its own olive oil PCs (250 ppm) plus thyme PCs (250 ppm; FOOT); and (3) a VOO with low phenolic content (80 ppm). Serum lipid and glycemic profiles, serum 1H-NMR spectroscopy-based metabolomics, endothelial function, blood pressure, and cardiovascular risk were measured. We combined OPLS-DA with machine learning modelling to identify metabolites discrimination of the treatment groups. Both phenol-enriched OO interventions decreased the levels of glutamine, creatinine, creatine, dimethylamine, and histidine in comparison to VOO one. In addition, FOOT decreased the plasma levels of glycine and DMSO2 compared to VOO, while FOO decreased the circulating alanine concentrations but increased the plasma levels of acetone and 3-HB compared to VOO. Based on these findings, phenol-enriched OOs were shown to result in a favorable shift in the circulating metabolic phenotype, inducing a reduction in metabolites associated with cardiometabolic diseases.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Virgin Olive Oil Phenolic Compounds Modulate the HDL Lipidome in Hypercholesterolaemic Subjects, A Lipidomic Analysis of the VOHF Study

  • Fernández-Castillejo, Sara|||0000-0002-8109-9713
  • Pedret, Anna
  • Catalán, Úrsula
  • Valls, Rosa Maria|||0000-0002-3351-0942
  • Farràs Mañé, Marta|||0000-0001-9776-3773
  • Rubió, Laura
  • Castañer, Olga|||0000-0003-3169-997X
  • Macià, Alba
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Motilva, Maria José
  • Covas Planells, Maria Isabel
  • Giera, Martin
  • Remaley, Alan T.
  • Solà, Rosa|||0000-0002-8359-235X
Scope: The lipidomic analysis of high-density lipoprotein (HDL) could be useful to identify new biomarkers of HDL function. Methods and results: A randomized, controlled, double-blind, crossover trial (33 hypercholesterolaemic subjects) is performed with a control virgin olive oil (VOO), VOO enriched with its own phenolic compounds (FVOO), or VOO enriched with additional phenolic compounds from thyme (FVOOT) for 3 weeks. HDL lipidomic analyses are performed using the Lipidyzer platform. VOO and FVOO intake increase monounsaturated-fatty acids (FAs) and decrease saturated and polyunsaturated FAs in triacylglyceride (TAG) species, among others species. In contrast, FVOOT intake does not induce these FAs changes. The decrease in TAG52:3(FA16:0) after VOO intake and the decrease in TAG52:5(FA18:2) after FVOO intake are inversely associated with changes in HDL resistance to oxidation. After FVOO intake, the decrease in TAG54:6(FA18:2) in HDL is inversely associated with changes in HDL cholesterol efflux capacity. Conclusion: VOO and FVOO consumption has an impact on the HDL lipidome, in particular TAG species. Although TAGs are minor components of HDL mass, the observed changes in TAG modulated HDL functionality towards a cardioprotective mode. The assessment of the HDL lipidome is a valuable approach to identify and characterize new biomarkers of HDL function.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

One-year longitudinal association between changes in dietary choline or betaine intake and cardiometabolic variables in the PREvención con DIeta MEDiterránea-Plus (PREDIMED-Plus) trial

  • Díez-Ricote, Laura
  • San-Cristobal, Rodrigo
  • Concejo, M José
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Corella, Dolores|||0000-0002-2366-4104
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Martínez, J Alfredo
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • López-Miranda, José|||0000-0002-8844-0718
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Bueno-Cavanillas, Aurora|||0000-0002-0649-3016
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Martín, Vicente|||0000-0003-0552-2804
  • Pintó, Xavier|||0000-0002-2216-2444
  • Gaforio, José J.|||0000-0003-2996-9301
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Mas, Sebastian|||0000-0001-6604-3327
  • Ros, Emilio|||0000-0002-2573-1294
  • Vázquez-Ruiz, Zenaida|||0000-0002-6828-9627
  • Ortega-Azorín, Carolina|||0000-0001-6719-9358
  • García-Gavilán, Jesús F.
  • Malcampo Manrúbia, Mireia|||0000-0002-1916-4537
  • Martínez-Urbistondo, Diego
  • Tojal-Sierra, Lucas|||0000-0001-5338-9601
  • García Rodríguez, Antonio
  • Gómez-Bellvert, Nuria
  • Chaplin, Alice
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Bernal-López, Rosa M.
  • Santos-Lozano, José M.
  • Basterra Gortari, Francisco Javier|||0000-0002-1506-2349
  • Sorlí, José V.|||0000-0002-0130-2006
  • Murphy, Michelle
  • Gasulla, Griselda|||0000-0003-4018-5786
  • Micó, Víctor
  • Salaverria-Lete, Itziar|||0000-0002-9504-4668
  • Goñi Ochandorena, Estibaliz
  • Babio, Nancy|||0000-0003-3527-5277
  • Herraiz, Xavier
  • Ordovás, José M.
  • Daimiel, Lidia|||0000-0001-9898-6629
Choline and betaine intakes have been related to cardiovascular health. We aimed to explore the relation between 1-y changes in dietary intake of choline or betaine and 1-y changes in cardiometabolic and renal function traits within the frame of the PREDIMED (PREvención con DIeta MEDiterránea)-Plus trial. We used baseline and 1-y follow-up data from 5613 participants (48.2% female and 51.8% male; mean ± SD age: 65.01 ± 4.91 y) to assess cardiometabolic traits, and 3367 participants to assess renal function, of the Spanish PREDIMED-Plus trial. Participants met ≥3 criteria of metabolic syndrome and had overweight or obesity [BMI (in kg/m 2) ≥27 and ≤40]. These criteria were similar to those of the PREDIMED parent study. Dietary intakes of choline and betaine were estimated from the FFQ. The greatest 1-y increase in dietary choline or betaine intake (quartile 4) was associated with improved serum glucose concentrations (-3.39 and -2.72 mg/dL for choline and betaine, respectively) and HbA1c levels (-0.10% for quartile 4 of either choline or betaine intake increase). Other significant changes associated with the greatest increase in choline or betaine intake were reduced body weight (-2.93 and -2.78 kg, respectively), BMI (-1.05 and -0.99, respectively), waist circumference (-3.37 and -3.26 cm, respectively), total cholesterol (-4.74 and -4.52 mg/dL, respectively), and LDL cholesterol (-4.30 and -4.16 mg/dL, respectively). Urine creatinine was reduced in quartile 4 of 1-y increase in choline or betaine intake (-5.42 and -5.74 mg/dL, respectively). Increases in dietary choline or betaine intakes were longitudinally related to improvements in cardiometabolic parameters. Markers of renal function were also slightly improved, and they require further investigation. This trial was registered at as ISRCTN89898870.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Metabolic syndrome criteria and severity and carbon dioxide (CO) emissions in an adult population

  • García, Silvia
  • Pastor, Rosario
  • Monserrat-Mesquida, Margalida
  • Álvarez-Álvarez, Laura
  • Rubín-García, María
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Corella, Dolores|||0000-0002-2366-4104
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • Lopez-Miranda, José
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Riquelme-Gallego, Blanca|||0000-0003-3422-7310
  • Pintó, Xavier|||0000-0002-2216-2444
  • Gaforio, José J.|||0000-0003-2996-9301
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Vázquez, Clotilde
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Ros, Emilio|||0000-0002-2573-1294
  • Sayón-Orea, Carmen|||0000-0002-4137-3263
  • Guillem-Saiz, Patricia
  • Valle Hita, Cristina|||0000-0001-5423-7466
  • Cabanes, Robert
  • Abete, Itziar|||0000-0002-6475-5387
  • Goicolea-Güemez, Leire
  • Gómez-Gracia, Enrique
  • Tercero-Maciá, Cristina
  • Colom, Antoni|||0000-0001-5041-0778
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Castro Barquero, Sara|||0000-0002-6876-5443
  • Fernández-García, José C.|||0000-0003-2229-8488
  • Santos-Lozano, José Manuel
  • Cenoz, Juan Carlos
  • Barragán, Rocío|||0000-0001-8072-3791
  • Khoury, Nadine
  • Castañer, Olga|||0000-0003-3169-997X
  • Zulet, M. Angeles|||0000-0002-3926-0892
  • Vaquero-Luna, Jessica
  • Bes-Rastrollo, Maira|||0000-0002-9139-4206
  • De las Heras-Delgado, Sara|||0000-0002-3439-5712
  • Ciurana, Ramon
  • Martín, Vicente|||0000-0003-0552-2804
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Bouzas, Cristina|||0000-0002-1407-8461
Metabolic syndrome (MetS) has become a growing risk factor of some non-communicable diseases. Increase of greenhouse gas emissions affects the planet. To assess the association between MetS severity and amount of carbon dioxide (CO) emitted in an adult population. Cross-sectional study (n = 6646; 55-76-year-old-men; 60-75-year-old-women with MetS). Dietary habits were assessed using a pre-validated semi quantitative 143-item food frequency questionnaire. The amount of CO emitted due to the production of food consumed by person and day was calculated using a European database, and the severity of the MetS was calculated with the MetS Severity Score. Higher glycaemia levels were found in people with higher CO emissions. The risk of having high severe MetS was related to high CO emissions. Low CO emissions diet would help to reduce MetS severity. Advantages for both health and the environment were found following a more sustainable diet. ISRCTN, . Registered 05 September 2013.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Role of NAFLD on the Health Related QoL Response to Lifestyle in Patients With Metabolic Syndrome, The PREDIMED Plus Cohort

  • Martínez-Urbistondo, Diego
  • San Cristóbal, RodrigoSan
  • Villares, Paula
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Babio, Nancy|||0000-0003-3527-5277
  • Corella, Dolores|||0000-0002-2366-4104
  • Del Val García, José Luis|||0000-0002-0391-9368
  • Ordovás, José M.
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • López-Miranda, José|||0000-0002-8844-0718
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, J. Luís
  • Bueno-Cavanillas, Aurora|||0000-0002-0649-3016
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Marcos, Alba
  • Pintó, Xavier|||0000-0002-2216-2444
  • Delgado-Rodríguez, Miguel
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Vázquez, Clotilde
  • Ros, Emilio|||0000-0002-2573-1294
  • Bullón Vela, María Vanessa
  • Palau Galindo, Antoni|||0000-0002-2512-0872
  • Masagué, Marta
  • Abete, Itziar|||0000-0002-6475-5387
  • Moreno-Rodríguez, Anai
  • Candela-García, Inma
  • Konieczna, Jadwiga|||0000-0002-2947-1338
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Juárez, Oscar Lecea
  • Martín, Paco
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Zulet, M. Angeles|||0000-0002-3926-0892
  • Vaquero-Luna, Jessica
  • Orea, María del Carmen Sayón
  • Megías, Isabel
  • Baltasar, Enric
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Daimiel, Lidia|||0000-0001-9898-6629
To evaluate the effect of Non-alcoholic fatty liver disease (NAFLD) status in the impact of lifestyle over Health-related quality of life (HRQoL) in patients with metabolic syndrome (MetS). Baseline and 1 year follow up data from the PREDIMED-plus cohort (men and women, 55-75 years old with overweight/obesity and MetS) were studied. Adherence to an energy-restricted Mediterranean Diet (er-MeDiet) and Physical Activity (PA) were assessed with a validated screeners. Hepatic steatosis index (HSI) was implemented to evaluate NAFLD while the SF-36 questionnaire provided HRQoL evaluation. Statistical analyses were performed to evaluate the influence of baseline NAFLD on HRQoL as affected by lifestyle during 1 year of follow up. Data from 5205 patients with mean age of 65 years and a 48% of female participants. Adjusted linear multivariate mixed regression models showed that patients with lower probability of NAFLD (HSI < 36 points) were more responsive to er-MeDiet (β 0.64 vs β 0.05 per er-MeDiet adherence point, p< 0.01) and PA (β 0.05 vs β 0.01 per MET-h/week, p = 0.001) than those with high probability for NAFLD in terms Physical SF-36 summary in the 1 year follow up. 10 points of er-MeDiet adherence and 50 MET-h/week were thresholds for a beneficial effect of lifestyle on HRQoL physical domain in patients with lower probability of NAFLD. The evaluation of NAFLD by the HSI index in patients with MetS might identify subjects with different prospective sensitivity to lifestyle changes in terms of physical HRQoL ().
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Longitudinal association of dietary acid load with kidney function decline in an older adult population with metabolic syndrome

  • Valle Hita, Cristina|||0000-0001-5423-7466
  • Becerra-Tomás, Nerea|||0000-0002-4429-6507
  • Díaz-López, Andrés|||0000-0002-7500-5629
  • Vázquez-Ruiz, Zenaida|||0000-0002-6828-9627
  • Megías, Isabel
  • Corella, Dolores|||0000-0002-2366-4104
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • López-Miranda, José|||0000-0002-8844-0718
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Bueno-Cavanillas, Aurora|||0000-0002-0649-3016
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Martín, Vicente|||0000-0003-0552-2804
  • Pintó, Xavier|||0000-0002-2216-2444
  • Gaforio, José J.|||0000-0003-2996-9301
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Amengual-Galbarte, Angela
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Ros, Emilio|||0000-0002-2573-1294
  • García-Arellano, Ana
  • Barragán, Rocío|||0000-0001-8072-3791
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Peña-Orihuela, Patricia J.
  • Asencio-Aznar, Alberto
  • Gómez-Gracia, Enrique
  • Martinez-Urbistondo, Diego
  • Morey, Marga
  • Casas, Rosa|||0000-0002-0211-9166
  • Garrido-Garrido, Eva María
  • Tojal-Sierra, Lucas|||0000-0001-5338-9601
  • Damas-Fuentes, Miguel
  • Goñi, Estibaliz
  • Ortega-Azorín, Carolina|||0000-0001-6719-9358
  • Castañer, Olga|||0000-0003-3169-997X
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Gisbert-Sellés, Cristina
  • Sayón-Orea, Carmen|||0000-0002-4137-3263
  • Schröder, Helmut|||0000-0003-2231-5081
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Babio, Nancy|||0000-0003-3527-5277
Diets high in acid load may contribute to kidney function impairment. This study aimed to investigate the association between dietary acid load and 1-year changes in glomerular filtration rate (eGFR) and urine albumin/creatinine ratio (UACR). Older adults with overweight/obesity and metabolic syndrome (mean age 65 ± 5 years, 48% women) from the PREDIMED-Plus study who had available data on eGFR (n = 5,874) or UACR (n = 3,639) at baseline and after 1 year of follow-up were included in this prospective analysis. Dietary acid load was estimated as potential renal acid load (PRAL) and net endogenous acid production (NEAP) at baseline from a food frequency questionnaire. Linear and logistic regression models were fitted to evaluate the associations between baseline tertiles of dietary acid load and kidney function outcomes. One year-changes in eGFR and UACR were set as the primary outcomes. We secondarily assessed ≥ 10% eGFR decline or ≥10% UACR increase. After multiple adjustments, individuals in the highest tertile of PRAL or NEAP showed higher one-year changes in eGFR (PRAL, β: -0.64 ml/min/1.73 m 2 ; 95% CI: -1.21 to -0.08 and NEAP, β: -0.56 ml/min/1.73 m 2 ; 95% CI: -1.13 to 0.01) compared to those in the lowest category. No associations with changes in UACR were found. Participants with higher levels of PRAL and NEAP had significantly higher odds of developing ≥10% eGFR decline (PRAL, OR: 1.28; 95% CI: 1.07-1.54 and NEAP, OR: 1.24; 95% CI: 1.03-1.50) and ≥10 % UACR increase (PRAL, OR: 1.23; 95% CI: 1.04-1.46) compared to individuals with lower dietary acid load. Higher PRAL and NEAP were associated with worse kidney function after 1 year of follow-up as measured by eGFR and UACR markers in an older Spanish population with overweight/obesity and metabolic syndrome.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A functional virgin olive oil enriched with olive oil and thyme phenolic compounds improves the expression of cholesterol efflux-related genes, A randomized, crossover, controlled trial

  • Farràs Mañé, Marta|||0000-0001-9776-3773
  • Arranz, Sara|||0000-0003-2397-5145
  • Carrión, Silvia|||0000-0002-1354-2488
  • Subirana, Isaac|||0000-0003-1676-0197
  • Muñoz Aguayo, Daniel|||0000-0001-8173-0168
  • Blanchart, Gemma|||0000-0003-1965-8235
  • Kool, Marjon
  • Solà, Rosa|||0000-0002-8359-235X
  • Motilva, María José
  • Escolà-Gil, Joan Carles|||0000-0001-9021-2485
  • Rubió, Laura
  • Fernández-Castillejo, Sara|||0000-0002-8109-9713
  • Pedret, Anna
  • Estruch, Ramón|||0000-0003-1260-4445
  • Covas Planells, Maria Isabel
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Hernáez, Álvaro|||0000-0001-8593-1477
  • Castañer, Olga|||0000-0003-3169-997X
The consumption of antioxidant-rich foods such as virgin olive oil (VOO) promotes high-density lipoprotein (HDL) anti-atherogenic capacities. Intake of functional VOOs (enriched with olive/thyme phenolic compounds (PCs)) also improves HDL functions, but the gene expression changes behind these benefits are not fully understood. Our aim was to determine whether these functional VOOs could enhance the expression of cholesterol efflux-related genes. In a randomized, double-blind, crossover, controlled trial, 22 hypercholesterolemic subjects ingested for three weeks 25 mL/day of: (1) a functional VOO enriched with olive oil PCs (500 mg/kg); (2) a functional VOO enriched with olive oil (250 mg/kg) and thyme PCs (250 mg/kg; FVOOT), and; (3) a natural VOO (olive oil PCs: 80 mg/kg, control intervention). We assessed whether these interventions improved the expression of cholesterol efflux-related genes in peripheral blood mononuclear cells by quantitative reverse-transcription polymerase chain reactions. The FVOOT intervention upregulated the expression of CYP27A1 (P = 0.041 and P = 0.053, versus baseline and the control intervention, respectively), CAV1 (P = 0.070, versus the control intervention), and LXRβ, RXRα, and PPARβ/δ (P = 0.005, P = 0.005, and P = 0.038, respectively, relative to the baseline). The consumption of a functional VOO enriched with olive oil and thyme PCs enhanced the expression of key cholesterol efflux regulators, such as CYP27A1 and nuclear receptor-related genes.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Phase II Trial of Allogeneic Transplantation Plus Novel Drugs in Multiple Myeloma, Effect of Intensifying Reduced-Intensity Conditioning with Bortezomib and Adding Maintenance Treatment

  • Reinoso-Segura, Marta|||0000-0002-1859-9803
  • Caballero Velazquez, Teresa|||0000-0001-7487-3793
  • Herrera, Pilar|||0000-0002-4118-7110
  • Patriarca, Francesca
  • Fanin, Renato
  • Bruno, Benedetto
  • Einsele, Hermann
  • Nahi, Hareth
  • Granell, Miquel|||0000-0002-0366-3673
  • López Corral, Lucia|||0000-0003-1908-5596
  • Reguera, Juan L.
  • García Cadenas, Irene|||0000-0002-2994-9055
  • Gahrton, Gösta
  • Pérez-Simón, José Antonio|||0000-0003-3616-6101
The use of reduced-intensity conditioning (RIC) regimens has decreased the risk of nonrelapse mortality (NRM) after allogeneic stem cell transplantation (alloSCT). In contrast, disease relapse remains the most frequent cause of treatment failure and death. Owing to both their antimyeloma effect and immunomodulatory properties, novel drugs could improve outcomes after alloSCT. This phase II European Myeloma Network trial was designed to evaluate the combination of alloSCT with novel agents. The study was conducted to evaluate the toxicity and efficacy of RIC intensified with bortezomib (Bz) prior to alloSCT for high-risk (HR) multiple myeloma (MM) patients, as well as the efficacy of post-transplantation maintenance with Bz and lenalidomide (Len). Patients received RIC with Bz on days -9 and -2, fludarabine on days -6 to -4, and melphalan on day -3. Patients who were in complete response (CR) or near CR at day +100 post-transplantation received 6 cycles of Bz every 56 days, and the remaining received Bz, Len, and dexamethasone. Len maintenance was started on day +180 at a dose of 5 mg and continued until relapse or toxicity occurred. Of the 24 patients included, 21 were evaluable on day +100, including 12 in CR, 4 in very good partial response, 3 in partial response, and 2 with relapse or progression. The cumulative incidence (CuI) of relapse was 13.6% (95% confidence interval [CI], 3.2% to 31.3%) at 1 year and 28.5% (95% CI, 11.1% to 48.9%) at 2 years. The CuI of NRM was 21.1% (95% CI, 7.4% to 39.4%) at 2 years. With a median follow-up of 39 months (range, 1 to 67 months), the median event-free survival (EFS) was 29 months, and median overall survival (OS) was not reached. EFS and OS at 3 years were 42.5% (95% CI, 21.9% to 61.7%) and 74.01% (95% CI, 50.9% to 87.5%), respectively. The use of Bz within an RIC regimen allows for a high response rate after alloSCT. Maintenance with Bz and Len is feasible and provides remarkable results in terms of EFS and OS in HR MM patients.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

CXCR7 expression in diffuse large B-cell lymphoma identifies a subgroup of CXCR4+ patients with good prognosis

  • Moreno, María José
  • Gallardo, Alberto|||0000-0002-2514-2027
  • Novelli, Silvana|||0000-0001-8750-0195
  • Mozos, Ana|||0000-0002-3350-1827
  • Aragó, Marc|||0000-0002-9645-0131
  • Pavón, Miguel Ángel|||0000-0003-3677-5329
  • Céspedes, María Virtudes|||0000-0003-2956-5833
  • Pallarès, Victor|||0000-0002-9851-0345
  • Falgàs, Aïda|||0000-0002-5040-2265
  • Alcoceba, Miguel|||0000-0002-3819-4846
  • Blanco, Oscar
  • González-Díaz, Marcos
  • Malouf Sierra, Jorge|||0000-0001-5185-520X
  • Mangues, Ramon|||0000-0003-2661-9525
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
The CXCR4/CXCL12 axis has been extensively associated with different types of cancer correlating with higher aggressiveness and metastasis. In diffuse large B-cell lymphoma (DLBCL), the expression of the chemokine receptor CXCR4 is involved in the dissemination of malignant B cells and is a marker of poor prognosis. CXCR7 is a chemokine receptor that binds to the same ligand as CXCR4 and regulates de CXCR4-CXCL12 axis. These findings together with the report of CXCR7 prognostic value in several tumor types, led us to evaluate the expression of CXCR7 in diffuse large B-cell lymphoma biopsies. Here, we describe that CXCR7 receptor is an independent prognostic factor that associates with good clinical outcome. Moreover, the expression of CXCR7 associates with increased survival in CXCR4 + but not in CXCR4- DLBCL patients. Thus, the combined immunohistochemical evaluation of both CXCR7 and CXCR4 expression in DLBCL biopsies may improve their prognostic value as single markers. Finally, we show that CXCR7 overexpression in vitro is able to diminish DLBCL cell survival and increase their sensitivity to antitumor drugs. Hence, further studies on the CXCR7 receptor may establish its role in DLBCL and the molecular mechanisms that modulate CXCR4 activity.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Morbid liver manifestations are intrinsically bound to metabolic syndrome and nutrient intake based on a machine-learning cluster analysis

  • Micó, Victor
  • San-Cristobal, Rodrigo
  • Martín, Roberto
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Corella, Dolores|||0000-0002-2366-4104
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • López-Miranda, José|||0000-0002-8844-0718
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, J. Luís
  • Bueno-Cavanillas, Aurora|||0000-0002-0649-3016
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Martín, Vicente|||0000-0003-0552-2804
  • Pintó, Xavier|||0000-0002-2216-2444
  • Delgado-Rodríguez, Miguel
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Vázquez, Clotilde
  • García-Arellano, Ana
  • Pertusa-Martinez, Salvador
  • Chaplin, Alice
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Muñoz Bravo, Carlos
  • Schröder, Helmut|||0000-0003-2231-5081
  • Babio, Nancy|||0000-0003-3527-5277
  • Sorlí, José V.|||0000-0002-0130-2006
  • Gonzalez, Jose I.
  • Martinez-Urbistondo, Diego
  • Toledo, Estefania|||0000-0002-6263-4434
  • Bullón, Vanessa
  • Ruiz-Canela, Miguel|||0000-0002-7684-2787
  • Portillo, María Puy
  • Macías-González, Manuel
  • Perez-Diaz-del-Campo, Nuria
  • García-Gavilán, Jesús
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Martínez, J Alfredo
Metabolic syndrome (MetS) is one of the most important medical problems around the world. Identification of patient's singular characteristic could help to reduce the clinical impact and facilitate individualized management. This study aimed to categorize MetS patients using phenotypical and clinical variables habitually collected during health check-ups of individuals considered to have high cardiovascular risk. The selected markers to categorize MetS participants included anthropometric variables as well as clinical data, biochemical parameters and prescribed pharmacological treatment. An exploratory factor analysis was carried out with a subsequent hierarchical cluster analysis using the z-scores from factor analysis. The first step identified three different factors. The first was determined by hypercholesterolemia and associated treatments, the second factor exhibited glycemic disorders and accompanying treatments and the third factor was characterized by hepatic enzymes. Subsequently four clusters of patients were identified, where cluster 1 was characterized by glucose disorders and treatments, cluster 2 presented mild MetS, cluster 3 presented exacerbated levels of hepatic enzymes and cluster 4 highlighted cholesterol and its associated treatments Interestingly, the liver status related cluster was characterized by higher protein consumption and cluster 4 with low polyunsaturated fatty acid intake. This research emphasized the potential clinical relevance of hepatic impairments in addition to MetS traditional characterization for precision and personalized management of MetS patients.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Associations Between the Modified Food Standard Agency Nutrient Profiling System Dietary Index and Cardiovascular Risk Factors in an Elderly Population

  • Khoury, Nadine
  • Gómez Donoso, Clara|||0000-0003-4753-3560
  • Martínez, María Ángeles
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Corella, Dolores|||0000-0002-2366-4104
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • León-Acuña, Ana
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Santos-Lozano, JM.|||0000-0001-7097-5653
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Massó, Paloma|||0000-0002-3519-9254
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Martín, Vicente|||0000-0003-0552-2804
  • Pintó, Xavier|||0000-0002-2216-2444
  • Delgado Rodríguez, M.|||0000-0002-3838-2548
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Vázquez, Clotilde
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Ros, Emilio|||0000-0002-2573-1294
  • Bes-Rastrollo, Maira|||0000-0002-9139-4206
  • Barragán, Rocío|||0000-0001-8072-3791
  • Castañer, Olga|||0000-0003-3169-997X
  • Torres-Peña, Jose David
  • Notario Barandiaran, Leyre|||0000-0003-0517-6307
  • Muñoz-Bravo, Carlos
  • Abete, Itziar|||0000-0002-6475-5387
  • Prohens, Lara
  • Cano-Ibáñez, Naomi|||0000-0002-3640-5486
  • Tojal-Sierra, Lucas|||0000-0001-5338-9601
  • Fernández García, José Carlos|||0000-0003-2308-2865
  • Sayón-Orea, Carmen|||0000-0002-4137-3263
  • Pascual, Maria
  • Sorlí, José V.|||0000-0002-0130-2006
  • Zomeño, María Dolores|||0000-0003-1280-7680
  • Peña-Orihuela, Patricia J.
  • Signes-Pastor, Antonio J.
  • Basterra Gortari, Francisco Javier|||0000-0002-1506-2349
  • Schröeder, Helmut
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Babio, Nancy|||0000-0003-3527-5277
Background: Helping consumers to improve the nutritional quality of their diet is a key public health action to prevent cardiovascular diseases (CVDs). The modified version of the Food Standard Agency Nutrient Profiling System Dietary Index (FSAm-NPS DI) underpinning the Nutri-Score front-of-pack label has been used in public health strategies to address the deleterious consequences of poor diets. This study aimed to assess the association between the FSAm-NPS DI and some CVD risk factors including body mass index (BMI), waist circumference, plasma glucose levels, triglyceride levels, high-density lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol, and diastolic and systolic blood pressure. Materials and Methods: Dietary intake was assessed at baseline and after 1 year of follow-up using a 143-item validated semi-quantitative food-frequency questionnaire. Dietary indices based on FSAm-NPS applied at an individual level were computed to characterize the diet quality of 5,921 participants aged 55-75 years with overweight/obesity and metabolic syndrome from the PREDIMED-plus cohort. Associations between the FSAm-NPS DI and CVD risk factors were assessed using linear regression models. Results: Compared to participants with a higher nutritional quality of diet (measured by a lower FSAm-NPS DI at baseline or a decrease in FSAm-NPS DI after 1 year), those participants with a lower nutritional quality of diet (higher FSAm-NPS DI or an increase in score) showed a significant increase in the levels of plasma glucose, triglycerides, diastolic blood pressure, BMI, and waist circumference (β coefficient [95% confidence interval]; P for trend) (1.67 [0.43, 2.90]; <0.001; 6.27 [2.46, 10.09]; <0.001; 0.56 [0.08, 1.05]; 0.001; 0.51 [0.41, 0.60]; <0.001; 1.19 [0.89, 1.50]; <0.001, respectively). No significant associations in relation to changes in HDL and LDL-cholesterol nor with systolic blood pressure were shown. Conclusion: This prospective cohort study suggests that the consumption of food items with a higher FSAm-NPS DI is associated with increased levels of several major risk factors for CVD including adiposity, fasting plasma glucose, triglycerides, and diastolic blood pressure. However, results must be cautiously interpreted because no significant prospective associations were identified for critical CVD risk factors, such as HDL and LDL-cholesterol, and systolic blood pressure.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Prospective associations between a priori dietary patterns adherence and kidney function in an elderly Mediterranean population at high cardiovascular risk

  • Valle Hita, Cristina|||0000-0001-5423-7466
  • Díaz-López, Andrés|||0000-0002-7500-5629
  • Becerra-Tomás, Nerea|||0000-0002-4429-6507
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Ruiz García, Verónica|||0000-0002-7405-2319
  • Corella, Dolores|||0000-0002-2366-4104
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • López-Miranda, José|||0000-0002-8844-0718
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Cano-Ibáñez, Naomi|||0000-0002-3640-5486
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Rubín García, María|||0000-0003-0916-4215
  • Pintó, Xavier|||0000-0002-2216-2444
  • Delgado Rodríguez, M.|||0000-0002-3838-2548
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Mas, Sebastian|||0000-0001-6604-3327
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Ros, Emilio|||0000-0002-2573-1294
  • Toledo, Estefania|||0000-0002-6263-4434
  • Sorlí, José V.|||0000-0002-0130-2006
  • Roca, C.
  • Abete, Itziar|||0000-0002-6475-5387
  • Moreno-Rodriguez, Anai
  • Crespo-Oliva, Edelys
  • Candela-García, Inmaculada
  • Morey, Marga
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Casas, Rosa|||0000-0002-0211-9166
  • Fernández García, José Carlos|||0000-0003-2308-2865
  • Santos-Lozano, JM.|||0000-0001-7097-5653
  • Diez-Espino, Javier
  • Ortega-Azorín, Carolina|||0000-0001-6719-9358
  • Comas, Mercè
  • Zulet, M. Angeles|||0000-0002-3926-0892
  • Sorto-Sanchez, Carolina
  • Ruiz-Canela, Miguel|||0000-0002-7684-2787
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Babio, Nancy|||0000-0003-3527-5277
To assess the association between three different a priori dietary patterns adherence (17-item energy reduced-Mediterranean Diet (MedDiet), Trichopoulou-MedDiet and Dietary Approach to Stop Hypertension (DASH)), as well as the Protein Diet Score and kidney function decline after one year of follow-up in elderly individuals with overweight/obesity and metabolic syndrome (MetS). We prospectively analyzed 5675 participants (55-75 years) from the PREDIMED-Plus study. At baseline and at one year, we evaluated the creatinine-based estimated glomerular filtration rate (eGFR) and food-frequency questionnaires-derived dietary scores. Associations between four categories (decrease/maintenance and tertiles of increase) of each dietary pattern and changes in eGFR (ml/min/1.73m) or ≥ 10% eGFR decline were assessed by fitting multivariable linear or logistic regression models, as appropriate. Participants in the highest tertile of increase in 17-item erMedDiet Score showed higher upward changes in eGFR (β: 1.87 ml/min/1.73m; 95% CI: 1.00-2.73) and had lower odds of ≥ 10% eGFR decline (OR: 0.62; 95% CI: 0.47-0.82) compared to individuals in the decrease/maintenance category, while Trichopoulou-MedDiet and DASH Scores were not associated with any renal outcomes. Those in the highest tertile of increase in Protein Diet Score had greater downward changes in eGFR (β: - 0.87 ml/min/1.73m; 95% CI: - 1.73 to - 0.01) and 32% higher odds of eGFR decline (OR: 1.32; 95% CI: 1.00-1.75). Among elderly individuals with overweight/obesity and MetS, only higher upward change in the 17-item erMedDiet score adherence was associated with better kidney function after one year. However, increasing Protein Diet Score appeared to have an adverse impact on kidney health. Trial Registration Number: ISRCTN89898870 (Data of registration: 2014).
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Deprivation Index and Lifestyle, Baseline Cross-Sectional Analysis of the PREDIMED-Plus Catalonia Study

  • Basora, Josep|||0000-0003-0278-1149
  • Villalobos, Felipe|||0000-0002-6907-8354
  • Pallejà-Millán, Meritxell|||0000-0003-1985-8894
  • Babio, Nancy|||0000-0003-3527-5277
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Zomeño, María Dolores|||0000-0003-1280-7680
  • Pintó, Xavier|||0000-0002-2216-2444
  • Sacanella, Emilio|||0000-0001-8018-1523
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
This baseline cross-sectional analysis from data acquired in a sub-sample of the PREDIMED-Plus study participants aimed to evaluate the relation between the Composite Socioeconomic Index (CSI) and lifestyle (diet and physical activity). This study involved 1512 participants (759 (52.2%) women) between 55 and 80 years with overweight/obesity and metabolic syndrome assigned to 137 primary healthcare centers in Catalonia, Spain. CSI and lifestyle (diet and physical activity) were assessed. Multiple linear regression or multinomial regression were applied to the data. Cluster analysis was performed to identify dietary patterns. The multiple linear regression model showed that a high deprivation index was related to a higher consumption of refined cereals (11.98 g/d, p -value = 0.001) and potatoes (6.68 g/d, p -value = 0.001), and to a lower consumption of fruits (-17.52 g/d, p -value = 0.036), and coffee and tea (-8.03 g/d, p -value = 0.013). Two a posteriori dietary patterns were identified by cluster analysis and labeled as "healthy" and "unhealthy". In addition, the multinomial regression model showed that a high deprivation index was related to an unhealthy dietary pattern and low physical activity (OR 1.42 [95% CI 1.06-1.89]; p -value < 0.05). In conclusion, a high deprivation index was related to an unhealthy lifestyle (diet and physical activity) in PREDIMED-Plus study participants.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Association between type 2 diabetes and depressive symptoms after a 1-year follow-up in an older adult Mediterranean population

  • Baenas Soto, Isabel Maria|||0000-0001-7415-0616
  • Camacho-Barcia, Lucía|||0000-0002-5989-936X
  • Granero, Roser|||0000-0001-6308-3198
  • Razquin, C.
  • Corella, D.
  • Gómez-Martínez, C.
  • Castañer-Niño, O.
  • Martínez, J. A.
  • Alonso-Gómez, Á. M.
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, D.
  • López-Miranda, J.
  • Estruch, R.
  • Tinahones, F. J.
  • Lapetra, J.
  • Serra-Majem, J. L.
  • Cano-Ibáñez, N.
  • Tur, J. A.
  • Martín, Vicente|||0000-0003-0552-2804
  • Pintó, Xavier|||0000-0002-2216-2444
  • Gaforio, J. J.
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, J.
  • Vázquez, C.
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Ros, E.
  • Jiménez Murcia, Susana|||0000-0002-3596-8033
  • Dalsgaard, S.
  • Garcia-Arellano, A.
  • Babio, Nancy|||0000-0003-3527-5277
  • Sorlí, José V.|||0000-0002-0130-2006
  • Lassale, C.
  • García-de-la-Hera, M.
  • Gómez-García, E.
  • Zulet, M. Angeles|||0000-0002-3926-0892
  • Konieczna, J.
  • Martín Peláez, Sandra|||0000-0002-2193-3913
  • Tojal-Sierra, Lucas|||0000-0001-5338-9601
  • Basterra-Gortari, F. J.
  • De las Heras-Delgado, Sara|||0000-0002-3439-5712
  • Portoles, O.
  • Muñoz, Miguel-Angel|||0000-0002-4083-3248
  • Arenas-Larriva, A. P.
  • Compañ Gabucio, Laura M.|||0000-0001-5324-1535
  • Eguaras, Sonia
  • Shyam, S.
  • Fitó, M.
  • Baños, Rosa|||0000-0003-0626-7665
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
To examine the cross-sectional association between baseline depressive symptoms and the presence of type 2 diabetes (T2D), and its association with glycated hemoglobin (HbA1c) and other metabolic variables, and the prospective association of depressive symptoms and HbA1c after 1 year of follow-up. n = 6224 Mediterranean older adults with overweight/obesity and metabolic syndrome (48% females, mean age 64.9 ± 4.9 years) were evaluated in the framework of the PREDIMED-Plus study cohort. Depressive symptoms were assessed using the Beck Depression Inventory-II and HbA1c was used to measure metabolic control. The presence of T2D increased the likelihood of higher levels of depressive symptoms (χ 2 = 15.84, p = 0.001). Polynomial contrast revealed a positive linear relationship (χ 2 = 13.49, p = 0.001), the higher the depressive symptoms levels, the higher the prevalence of T2D. Longitudinal analyses showed that the higher baseline depressive symptoms levels, the higher the likelihood of being within the HbA1c ≥ 7% at 1-year level (Wald-χ 2 = 24.06, df = 3, p < .001, for the full adjusted model). Additionally, depressive levels at baseline and duration of T2D predicted higher HbA1c and body mass index, and lower physical activity and adherence to Mediterranean Diet at 1 year of follow-up. This study supports an association between T2D and the severity of depressive symptoms, suggesting a worse metabolic control from mild severity levels in the short-medium term, influenced by lifestyle habits related to diabetes care. Screening for depressive symptoms and a multidisciplinary integrative therapeutic approach should be ensured in patients with T2D.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Psychological and metabolic risk factors in older adults with a previous history of eating disorder, A cross-sectional study from the Predimed-Plus study

  • Vintró Alcaraz, Cristina|||0000-0001-9453-8810
  • Baenas Soto, Isabel Maria|||0000-0001-7415-0616
  • Lozano Madrid, María|||0000-0003-3833-317X
  • Granero, Roser|||0000-0001-6308-3198
  • Ruiz-Canela, Miguel|||0000-0002-7684-2787
  • Babio, Nancy|||0000-0003-3527-5277
  • Corella, Dolores|||0000-0002-2366-4104
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Vioque, Jesús|||0000-0002-2284-148X
  • Romaguera, Dora|||0000-0002-5762-8558
  • López-Miranda, José|||0000-0002-8844-0718
  • Estruch, Ramón|||0000-0003-1260-4445
  • Bernal-Lopez, María Rosa|||0000-0002-0238-0890
  • Lapetra, José|||0000-0002-3873-5737
  • Sanchez Villegas, Almudena|||0000-0001-7733-9238
  • Bueno-Cavanillas, Aurora|||0000-0002-0649-3016
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • Martín, Vicente|||0000-0003-0552-2804
  • Pintó, Xavier|||0000-0002-2216-2444
  • Delgado Rodríguez, M.|||0000-0002-3838-2548
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Vidal, Josep|||0000-0002-4564-4518
  • Cárdenas, Jersy J.|||0000-0002-2485-484X
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Ros, Emilio|||0000-0002-2573-1294
  • Razquín, Cristina|||0000-0003-3480-2645
  • Díaz-López, Andrés|||0000-0002-7500-5629
  • González, José I.
  • Forcano, Laura|||0000-0002-8478-1451
  • Zulet, M. Angeles|||0000-0002-3926-0892
  • Bello-Mora, Maria C.
  • Valenzuela-Guerrero, Silvia|||0000-0001-7467-8672
  • Garcia de La Hera, Manoli|||0000-0001-5742-2704
  • Konieczna, Jadwiga|||0000-0002-2947-1338
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Casas, Rosa|||0000-0002-0211-9166
  • Gómez-Pérez, Ana M
  • Garcia Arellano, Ana|||0000-0003-1491-9627
  • Bulló, Mònica|||0000-0002-0218-7046
  • Sorlí, José V.|||0000-0002-0130-2006
  • Cuenca-Royo, Aida|||0000-0001-8551-5457
  • Abete, Itziar|||0000-0002-6475-5387
  • Salaverria-Lete, Itziar|||0000-0002-9504-4668
  • Basterra Gortari, Francisco Javier|||0000-0002-1506-2349
  • Torre, Rafael de la|||0000-0002-6765-1866
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
Goals: To explore affective and cognitive status, later in life, in individuals with and without previous history of eating disorder (ED), and also its association with higher risk for metabolic syndrome (MetS) symptomatology. Methods: A cross-sectional analysis of 6756 adults, aged 55-75 years with overweight/obesity and MetS participating in the Predimed-Plus study was conducted. Participants completed self-reported questionnaires to examine lifetime history of ED, according to DSM-5 criteria, and other psychopathological and neurocognitive factors. Anthropometric and metabolic measurements were also collected. Results: Of the whole sample, 24 individuals (0.35%) reported a previous history of ED. In this subsample, there were more women and singles compared to their counterparts, but they also presented higher levels of depressive symptoms and higher cognitive impairment, but also higher body mass index (BMI) and severe obesity, than those without lifetime ED. Conclusions: This is one of the first studies to analyse the cognitive and metabolic impact of a previous history of ED. The results showed that previous ED was associated with greater affective and cognitive impairment, but also with higher BMI, later in life. No other MetS risk factors were found, after controlling for relevant variables.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients

  • Medina, Alejandro
  • Jimenez, Cristina
  • Sarasquete, Maria Eugenia
  • González, Marcos
  • Chillón, M. Carmen
  • Balanzategui, Ana
  • Gironella Mesa, Mercedes
Investigació genètica; Mieloma, Investigación genética; Mieloma, Genetics research; Myeloma, Multiple myeloma is a heterogeneous disease whose pathogenesis has not been completely elucidated. Although B-cell receptors play a crucial role in myeloma pathogenesis, the impact of clonal immunoglobulin heavy-chain features in the outcome has not been extensively explored. Here we present the characterization of complete heavy-chain gene rearrangements in 413 myeloma patients treated in Spanish trials, including 113 patients characterized by next-generation sequencing. Compared to the normal B-cell repertoire, gene selection was biased in myeloma, with significant overrepresentation of IGHV3, IGHD2 and IGHD3, as well as IGHJ4 gene groups. Hypermutation was high in our patients (median: 8.8%). Interestingly, regarding patients who are not candidates for transplantation, a high hypermutation rate (≥7%) and the use of IGHD2 and IGHD3 groups were associated with improved prognostic features and longer survival rates in the univariate analyses. Multivariate analysis revealed prolonged progression-free survival rates for patients using IGHD2/IGHD3 groups (HR: 0.552, 95% CI: 0.361−0.845, p = 0.006), as well as prolonged overall survival rates for patients with hypermutation ≥7% (HR: 0.291, 95% CI: 0.137−0.618, p = 0.001). Our results provide new insights into the molecular characterization of multiple myeloma, highlighting the need to evaluate some of these clonal rearrangement characteristics as new potential prognostic markers., This work was partially supported by the Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Economy and Competitiveness PI15/01956, CIBERONC-CB16/12/00233, and “Una manera de hacer Europa” (Innocampus; CEI-2010-1-0010)”. M.G.-A., I.P.-C., and C.J. are supported by the Fundación Española de Hematología y Hemoterapia (FEHH, co-funded by Fundación Cris in the latter case), A.M. by the European Social Fund and the Spanish Education Council through the University of Salamanca, and M.E.S. by the ISCIII (CPII18/00028). All Spanish funding is co-sponsored by the European Union FEDER program. The authors wish to thank José Pérez, Alicia Antón, Montserrat Hernández-Ruano, Estrella Arnés, Rebeca Maldonado, Mercedes Jiménez, Alejandra Martín, Isabel Sánchez, Rocío Corral and Francisco Boix (University Hospital of Salamanca, Spain) for their technical support, as well as the Spanish Multiple Myeloma “GEM-PETHEMA” group for providing clinical data. The authors are also very grateful to the patients who participated in this study.
e_Buah Biblioteca Digital Universidad de Alcalá
Publication Artículo científico (JournalArticle)

Tuning melatonin receptor subtype selectivity in oxadiazolone-based analogues: Discovery of QR2 ligands and NRF2 activators with neurogenic properties

  • Herrera Arozamena, Clara
  • Estrada Valencia, Martín
  • Pérez, Concepción
  • Lagartera Ortiz, Laura
  • Morales García, Jose Ángel
  • Pérez Castillo, Ana
  • Franco Gonzalez, Juan Felipe
  • Michalska, Patrycja
  • Duarte Flórez, Pablo
  • León Martínez, Rafael
  • García López, Manuela
  • Mills Fernández, Alberto|||0000-0003-4819-1638
  • Gago Badenas, Federico|||0000-0002-3071-4878
  • García Yagüe, Ángel Juan
  • Fernández Ginés, Raquel
  • Cuadrado Pastor, Antonio
  • Rodríguez Franco, María Isabel
24 p., New multi-target indole and naphthalene derivatives containing the oxadiazolone scaffold as a bioisostere of the melatonin acetamido group have been developed. The novel compounds were characterized at melatonin receptors MT1R and MT2R, quinone reductase 2 (QR2), lipoxygenase-5 (LOX-5), and monoamine oxidases (MAO-A and MAO-B), and also as radical scavengers. We found that selectivity within the oxadiazolone series can be modulated by modifying the side chain functionality and co-planarity with the indole or naphthalene ring. In phenotypic assays, several oxadiazolone-based derivatives induced signalling mediated by the transcription factor NRF2 and promoted the maturation of neural stem-cells into a neuronal phenotype. Activation of NRF2 could be due to the binding of indole derivatives to KEAP1, as deduced from surface plasmon resonance (SPR) experiments. Molecular modelling studies using the crystal structures of QR2 and the KEAP1 Kelch-domain, as well as the recently described X-ray free-electron laser (XFEL) structures of chimeric MT1R and MT2R, provided a rationale for the experimental data and afforded valuable insights for future drug design endeavours., Ministerio de Ciencia, Innovación y Universidades, Agencia Española de Investigación, Fondo Europeo de Desarrollo Regional (FEDER), Comunidad de Madrid, Instituto de Salud Carlos III, Ministerio de Educación y Ciencia, Ministerio de Economía y Competitividad
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Breakfast energy intake and dietary quality and trajectories of cardiometabolic risk factors in older adults

  • Pérez-Vega, Karla-Alejandra
  • Lassale, Camille
  • Zomeño, María Dolores
  • Castañer, Olga
  • Salas-Salvadó, Jordi
  • Basterra Gortari, Francisco Javier
  • Corella, Dolores
  • Estruch, Ramón
  • Ros, Emilio
  • Tinahones, Francisco J.
  • Blanchart, Gemma
  • Malcampo, Mireia
  • Muñoz-Aguayo, Daniel
  • Schröder, Helmut
  • Fitó, Montserrat
  • Hernáez, Álvaro
Objectives: Not skipping breakfast is associated with a better overall diet quality and lower cardiometabolic risk. However, the impact of calorie intake and dietary quality of breakfast on cardiovascular health remains unexplored. We aimed to study the associations between breakfast energy intake and quality and time trajectories of cardiometabolic traits in high cardiovascular risk participants. Design: Prospective observational exploratory study with repeated measurements. Setting: Spanish older adults. Participants: 383 participants aged 55-75 with metabolic syndrome from PREDIMED-Plus, a clinical trial involving a weight-loss lifestyle intervention based on the Mediterranean diet. Measurements: Participants were followed for 36 months. Longitudinal averages of breakfast energy intake and quality were calculated. Three categories were defined for energy intake: 20-30% (reference), <20% (low), and >30% (high). Quality was estimated using the Meal Balance Index; categories were above (reference) or below the median score (low). Natural cubic spline mixed effects regressions described trajectories of cardiometabolic indicators (anthropometry, blood pressure, lipids, glucose, glycated hemoglobin, and kidney function) in breakfast groups. Inter-group differences in predicted values were estimated by linear regressions. Analyses were adjusted for age, sex, PREDIMED-Plus intervention group, education, smoking, physical activity, and total daily kilocalorie intake. Lipid profile analyses were further adjusted for baseline hypercholesterolemia, blood pressure analyses for baseline hypertension, and glucose/glycated hemoglobin analyses for baseline diabetes. Breakfast energy intake analyses were adjusted for breakfast quality, and vice versa. Results: At 36 months, compared to the reference, low- or high-energy breakfasts were associated with differences in body mass index (low: 0.61 kg/m² [95% confidence interval: 0.19; 1.02]; high: 1.18 kg/m² [0.71; 1.65]), waist circumference (low: 2.22 cm [0.96; 3.48]; high: 4.57 cm [3.13; 6.01]), triglycerides (low: 13.8 mg/dL [10.8; 16.8]; high: 28.1 cm [24.7; 31.6]), and HDL cholesterol (low: -2.13 mg/dL [-3.41; -0.85]; high: -4.56 mg/dL [-6.04; -3.09]). At 36 months, low-quality breakfast was associated with higher waist circumference (1.50 cm [0.53; 2.46]), and triglycerides (5.81 mg/dL [3.50; 8.12]) and less HDL cholesterol (-1.66 mg/dL [-2.63; -0.69]) and estimated glomerular filtration rate (-1.22 mL/min/1.73m2 [-2.02; -0.41]). Conclusions: Low- or high-energy and low-quality breakfasts were associated with higher adiposity and triglycerides, and lower HDL cholesterol in high-risk older adults. Low-quality breakfasts were also linked to poorer kidney function., This work was supported by the Instituto de Salud Carlos III [grant numbers IFI20/00002, PI19/00017, PI15/00047, PI18/00020, PI16/00533, PI13/00233, PI21/00024, PI20/00012, and CP21/00097] and co-funded by the European Union, the European Research Council [grant number #340918], and the Government of Catalonia [grant number 2021 SGR 00144]. Publication fees were covered by the Blanquerna School of Health Sciences, University Ramon Llull in Barcelona.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Higher versus lower nut consumption and changes in cognitive performance over two years in a population at risk of cognitive decline: a cohort study

  • Ni, Jiaqi
  • Nishi, Stephanie K.
  • Babio, Nancy
  • Ros, Emilio
  • Basterra Gortari, Francisco Javier
  • Corella, Dolores
  • Castañer, Olga
  • Martínez, José Alfredo
  • Alonso Gómez, Ángel M.
  • Wärnberg, Julia
  • Vioque, Jesús
  • Romaguera, Dora
  • López Miranda, José
  • Estruch, Ramón
  • Tinahones, Francisco J.
  • Santos Lozano, José Manuel
  • Serra-Majem, Lluis
  • Cano Ibáñez, Noemí
  • Tur, Josep A.
  • Fernández-García, José Manuel
  • Pintó, Xavier
  • Delgado Rodríguez, Miguel
  • Matía-Martín, Pilar
  • Vidal, Josep
  • Vázquez, Clotilde
  • Daimiel, Lidia
  • Fernández-Aranda, Fernando
  • Ruiz Canela, Miguel
  • Mestres Solà, Cristina
  • Portolés, Olga
  • Sala Vila, Aleix
  • García-Ríos, Antonio
  • Compañ-Gabucio, Laura María
  • Gómez-Gracia, Enrique
  • Zulet, María Ángeles
  • Chaplin, Alice
  • Casas, Rosa
  • Martínez Diz, Silvia
  • Tojal-Sierra, Lucas
  • Gómez Pérez, Ana María
  • Toledo, Estefanía
  • Ríos, Santiago
  • Ortega Azorín, Carolina
  • Torre, Rafael de la
  • Peña-Orihuela, Patricia J.
  • García de la Hera, Manuela
  • Sayón-Orea, Carmen
  • Malcampo, Mireia
  • Salas-Salvadó, Jordi
Background: Tree nuts and peanuts (henceforth, nuts) are nutrient-dense foods rich in neuroprotective components; thus, their consumption could benefit cognitive health. However, evidence to date is limited and inconsistent regarding the potential benefits of nuts for cognitive function. Objective: To prospectively evaluate the association between nut consumption and 2-y changes in cognitive performance in older adults at cognitive decline risk. Methods: A total of 6,630 participants aged 55 to 75 y (mean age 65.04.9 y, 48.4% women) with overweight/obesity and metabolic syndrome completed a validated semi-quantitative food frequency questionnaire and a comprehensive battery of neuropsychological tests at baseline and a 2-y follow-up. Composite cognitive scores were used to assess global, general, attention, and executive function domains. Nut consumption was categorized as <1, 1 to <3, 3 to <7, and 7 servings/wk (1 serving¼30 g). Multivariable-adjusted linear regression models were fitted to assess associations between baseline nut consumption and 2-y cognitive changes. Results: Nut consumption was positively associated with 2-y changes in general cognitive function (P-trend <0.001). Compared with participants consuming <1 serving/wk of nuts, those categorized as consuming 3 to <7 and 7 servings/wk showed more favorable changes in general cognitive performance (β z-score [95% CI] ¼ 0.06 [0.00,0.12] and 0.13 [0.06,0.20], respectively). No significant changes were observed in the multivariableadjusted models for other cognitive domains assessed. Conclusion: Frequent nut consumption was associated with a smaller decline in general cognitive performance over 2 y in older adults at risk of cognitive decline. Randomized clinical trials to verify our findings are warranted., This work was supported by the official Spanish Institutions for funding scientific biomedical research, CIBER Fisiopatología de la Obesidad y Nutricion (CIBEROBN) and Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigacion para la Salud (FIS), which is co-funded by the European Regional Development Fund (6 coordinated FIS projects leaded by JS-S and JoV, including the following projects: PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/ 00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/ 01919, PI14/00853, PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/ 00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/ 00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/ 00017, PI19/01226, PI19/00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/ 00886, PI20/01158); the Especial Action Project entitled: Implementacion y evaluacion de una intervencion intensiva sobre la actividad física Cohorte PREDIMED-Plus grant and the Recercaixa (number 2013ACUP00194) grant to JS-S; grants from the European Research Council (Advanced Research Grant 2014–2019; agreement #340918); grants from the Consejería de Salud de la Junta de Andalucía (PI0458/2013, PS0358/2016, PI0137/2018); the PROMETEO/2017/ 017 and PROMETEO/2021/021 grants from the Consellería de Innovacion, Universidades, Ciencia y Sociedad digital de la Generalitat Valenciana; Grant PID2019-108858RB-I00 funded by AEI 10.13039/ 501100011033 and by “ERDF A way of making Europe”; the SEMERGEN grant; the AICO/2021/347 grants from the Generalitat Valenciana. This research was also partially funded by EU-H2020 Grants (Eat2beNICE/ H2020-SFS-2016-2); and the Horizon 2020 PRIME study (Prevention and Remediation of Insulin Multimorbidity in Europe; grant agreement #847879). JN is supported by a predoctoral grant from Ministerio de Ciencia, Innovacion y Universidades (FPU 20/ 00385). SKN is supported by a postdoctoral fellowship from the Canadian Institutes of Health Research (CIHR). JS-S, the senior author of this paper, was partially supported by ICREA under the ICREA Academia program.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Adherence to the Mediterranean diet and frailty criteria in an old population with metabolic syndrome: a cross-sectional analysis

  • Torrego Ellacuría, Macarena
  • Cuesta Triana, Federico
  • Ortiz Ramos, María
  • Martínez González, Miguel Ángel
  • Corella, Dolores
  • Vázquez-Lorente, Héctor
  • Fitó, Montserrat
  • Martínez, José Alfredo
  • Tojal-Sierra, Lucas
  • Wärnberg, Julia
  • Vioque, Jesús
  • Romaguera, Dora
  • López Miranda, José
  • Estruch, Ramón
  • Tinahones, Francisco J.
  • Santos-Lozano, J. M.
  • Serra-Majem, Lluis
  • Bueno-Cavanillas, A.
  • Tur, Josep A.
  • Romero Vigara, Juan Carlos
  • Pintó, Xavier
  • Gaforio, José J.
  • Vidal, Josep
  • Mas-Fontao, Sebastián
  • Daimiel, Lidia
  • Chiva-Blanch, Gema
  • Basterra Gortari, Francisco Javier
  • Gutierrez, Liliana
  • Sorli, Jose V.
  • Minguella Muñoz, Elisa
  • García-Ríos, Antonio
  • Bernabé Casanova, Andrea
  • Gómez-Gracia, Enrique
  • Zulet, María Ángeles
  • Nafría, Mar
  • Casas, Rosa
  • Garrido-Garrido, Eva M.
  • Goicolea-Güemez, Leire
  • Gómez Pérez, Ana María
  • Ruiz Canela, Miguel
  • Megias, Isabel
  • Valero Barceló, Carmen
  • Montenegro Calvo, Marina
  • Peña-Orihuela, Patricia J.
  • Tercero Marciá, Cristina
  • Razquin, Cristina
  • Babio, Nancy
  • Sala de Vedruna, Adriana
  • Barabash Bustelo, Ana
  • Matía-Martín, Pilar
Objectives: Frailty has emerged as a key indicator of biological aging. This study aimed to assess the relationship between MedDiet adherence and frailty prevalence in the context of metabolic syndrome (MetS). Design: Cross-sectional study. Baseline data from PREDIMED-Plus trial Setting: Primary care health, 23 recruitment sites (2013–2016). Participants: A total of 6874 participants with overweight/obesity and ≥3 MetS components. Measurements: Adherence to the MedDiet: 17-item MedDiet score. Frailty and prefrailty (3 or 1–2 criteria): modified Fried Frailty Index (FFI), considering exhaustion, physical activity and functional capacity. Main independent variable was analysed: as a continuous variable (range: 0–17); in quartiles of adherence using univariate and multivariate logistic regression models adjusted for potential confounders. Results: Prefrailty and frailty prevalence were 49.7% and 2.9%, respectively. Compared to those with the lowest MedDiet adherence (0–6), participants with the highest adherence (11–17) had significantly lower odds of meeting frailty criteria. Fully adjusted models showed ORs of 0.479 (p = 0.097) for frailty, 0.705 (p = 0.001) for prefrailty, and 0.694 (p = 0.001) for frailty or prefrailty in participants with higher/greater MedDiet adherence. Each 1-point increase in the 17-item score was associated with an OR ranging from 0.878 to 0.977 (p < 0.05 for all comparisons, except functional capacity: p = 0.100). When adherence was dichotomized, the adjusted ORs ranged from 0.406 to 0.834 (p < 0.05 for all comparisons). Conclusions: Higher adherence to MedDiet was associated with a lower prevalence of frailty and prefrailty in older adults with overweight/obesity and MetS, reinforcing its potential role in promoting healthy aging despite cardiometabolic comorbidities., This work was supported by official Spanish Institutions for funding scientific biomedical research, CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN) and Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigación para la Salud (FIS), which is cofunded by the European Regional Development Fund(six coordinated FIS projects including the following projects: PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/00017, PI19/01226, PI19/00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158); an NIH grant1R01DK127601, the European Research Council advanced research grant 2014–2019; agreement 340918, and the Especial Action Project entitled: Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-Plus grant; the Recercaixa grant (2013ACUP00194); grants from the Consejería de Salud de la Junta de Andalucía (PI0458/2013,PS0358/2016,PI0137/2018); the PROMETEO/2017/017 grant from the Generalitat Valenciana; the SEMERGENgrant; INSA-Ma María de Maeztu Unit of Excellence (grant CEX2021-001234-M funded by MICIN/AEI/FEDER, UE); Juan de la Cierva Research Grant (IJC2019-042420-I/AEI/ 10.13039/501100011033) from Agencia Estatal de Investigación to J.K., and a contract financed by the Government of the Balearic Islands Funds was partially supported by ICREA under the ICREA Academia program; Nutrition Grant from the Sociedad Española de Endocrinología y Nutrición Foundation(FSEEN, 2022) to PMM. HVL was funded by a research grant from the Agència de Gestió d’Ajuts Universitaris de Recerca via Unión Europea, Next Generation EU(AGAUR, record number: 2023POST-INV-01)
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Contribution of cardio-vascular risk factors to depressive status in the PREDIMED-PLUS Trial. A cross-sectional and a 2-year longitudinal study

  • Martín Peláez, Sandra
  • Serra-Majem, Lluis
  • Cano Ibáñez, Noemí
  • Martínez González, Miguel Ángel
  • Salas-Salvadó, Jordi
  • Corella, Dolores
  • Lassale, Camille
  • Martínez, José Alfredo
  • Alonso Gómez, Ángel M.
  • Wärnberg, Julia
  • Vioque, Jesús
  • Romaguera, Dora
  • López Miranda, José
  • Estruch, Ramón
  • Tinahones, Francisco J.
  • Lapetra, José
  • Fernández-Aranda, Fernando
  • Bueno Cavanillas, Aurora
  • Tur, Josep A.
  • Martín, Vicente
  • Pintó, Xavier
  • Delgado Rodríguez, Miguel
  • Matía-Martín, Pilar
  • Vidal, Josep
  • Vázquez, Clotilde
  • Daimiel, Lidia
  • Ros, Emilio
  • Toledo, Estefanía
  • Nishi, Stephanie K.
  • Sorli, Jose V.
  • Malcampo, Mireia
  • Zulet, María Ángeles
  • Moreno Rodríguez, Anaí
  • Cueto Galán, Raquel
  • Vivancos Aparicio, Diego
  • Colom Fernández, Antoni
  • García-Ríos, Antonio
  • Casas, Rosa
  • Bernal López, M. Rosa
  • Santos Lozano, José Manuel
  • Vázquez, Zenaida
  • Gómez-Martínez, Carlos
  • Ortega Azorín, Carolina
  • Val, José Luis del
  • Abete, Itziar
  • Goikoetxea Bahon, Amaia
  • Pascual, Elena
  • Becerra-Tomás, Nerea
  • Chillarón, Juan J.
  • Sánchez Villegas, María Almudena
Background Cardio-vascular disease and depression are thought to be closely related, due to shared risk factors. The aim of the study was to determine the association between cardio-vascular risk (CVR) factors and depressive status in a population (55-75 years) with metabolic syndrome (MetS) from the PREDIMED-Plus trial. Methods and findings Participants were classified into three groups of CVR according to the Framingham-based REGICOR function: (1) low (LR), (2) medium (MR) or (3) high/very high (HR). The Beck Depression Inventory-II (BDI-II) was used to assess depressive symptoms at baseline and after 2 years. The association between CVR and depressive status at baseline (n = 6545), and their changes after 2 years (n = 4566) were evaluated through multivariable regression models (logistic and linear models). HR women showed higher odds of depressive status than LR [OR (95% CI) = 1.78 (1.26, 2.50)]. MR and HR participants with total cholesterol <160 mg/mL showed higher odds of depression than LR [OR (95% CI) = 1.77 (1.13, 2.77) and 2.83 (1.25, 6.42) respectively)] but those with total cholesterol ¿280 mg/mL showed lower odds of depression than LR [OR (95% CI) = 0.26 (0.07, 0.98) and 0.23 (0.05, 0.95), respectively]. All participants decreased their BDI-II score after 2 years, being the decrease smaller in MR and HR diabetic compared to LR [adjusted mean±SE = -0.52±0.20, -0.41 ±0.27 and -1.25±0.31 respectively). MR and HR participants with total cholesterol between 240-279 mg/mL showed greater decreases in the BDI-II score compared to LR (adjusted mean±SE = -0.83±0.37, -0.77±0.64 and 0.97±0.52 respectively). Conclusions Improving cardiovascular health could prevent the onset of depression in the elderly. Diabetes and total cholesterol in individuals at high CVR, may play a specific role in the precise response., The PREDIMED-Plus trial was supported by the European Research Council through a grant to MAM (Advanced Research Grant 2013-2018; 340918). The project was also supported by the official funding agency for biomedical research of the Spanish Government (ISCIII) through the Fondo de Investigación para la Salud (FIS), which is co-funded by the European Regional Development Fund (four coordinated FIS projects), who awarded grants to JS and JV (PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732 and PI17/00926). The International Nut&Dried Fruit Council-FESNAD also provided funding through a grant to MAM (201302), and Recercaixa also awarded a grant to JS (2013ACUP00194). The Department of Health, Generalitat de Cataluña by the calls 'Acció instrumental de programes de recerca orientats en lámbit de la recercaila innovació en salut' and 'Pla estrategic de recerca i innovació en salut (PERIS),' also awarded a grant to FF (SLT006/17/00246). This research was also partially funded by: Consejería de Salud de la Junta de Andalucía (PI0458/2013, PS0358/2016, PI0137/2018); Generalitat Valenciana (PROMETEO/2017/017); SEMERGEN, CIBEROBN, FEDER and ISCIII (CB06/03); EU-H2020 Grants (Eat2beNICE/h2020-sfs-2016-2, ref.728018; PRIME/h2020-SC1-BHC-2018-2020, ref: 847879).
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Dairy product consumption and changes in cognitive performance: two-year analysis of the PREDIMED-Plus Cohort

  • Ni, Jiaqi
  • Nishi, Stephanie K.
  • Babio, Nancy
  • Martínez González, Miguel Ángel
  • Corella, Dolores
  • Castañer, Olga
  • Martínez, José Alfredo
  • Alonso Gómez, Ángel M.
  • Gómez-Gracia, Enrique
  • Vioque, Jesús
  • Romaguera, Dora
  • López Miranda, José
  • Estruch, Ramón
  • Tinahones, Francisco J.
  • Lapetra, José
  • Serra-Majem, Lluis
  • Bueno Cavanillas, Aurora
  • Tur, Josep A.
  • Martín-Sánchez, Vicente
  • Pintó, Xavier
  • Gaforio, José J.
  • Barabash Bustelo, Ana
  • Vidal, Josep
  • Vázquez, Clotilde
  • Daimiel, Lidia
  • Ros, Emilio
  • Toledo, Estefanía
  • Coltell, Oscar
  • Gómez-Martínez, Carlos
  • Zomeño, María Dolores
  • Donat Vargas, Carolina
  • Goicolea-Güemez, Leire
  • Bouzas, Cristina
  • García de la Hera, Manuela
  • Chaplin, Alice
  • García-Ríos, Antonio
  • Casas, Rosa
  • Cornejo-Pareja, Isabel
  • Santos Lozano, José Manuel
  • Rognoni, Teresa
  • Saiz, Carmen
  • Paz-Graniel, Indira
  • Malcampo, Mireia
  • Sánchez Villegas, María Almudena
  • Salaverria-Lete, Itziar
  • García-Arellano, Ana
  • Schröder, Helmut
  • Salas-Salvadó, Jordi
Scope: Dairy consumption has been suggested to impact cognition; however, evidence is limited and inconsistent. This study aims to longitudinally assess the association between dairy consumption with cognitive changes in an older Spanish population at high cardiovascular disease risk. Methods and results: Four thousand six hundred sixty eight participants aged 55–75 years, completed a validated food frequency questionnaire at baseline and a neuropsychological battery of tests at baseline and 2-year follow-up. Multivariable linear regression models are used, scaled by 100 (i.e., the units of β correspond to 1 SD/100), to assess associations between baseline tertile daily consumption and 2-year changes in cognitive performance. Participants in the highest tertile of total milk and whole-fat milk consumption have a greater decline in global cognitive function (β: –4.71, 95% CI: –8.74 to –0.69, p-trend = 0.020 and β: –6.64, 95% CI: –10.81 to –2.47, p-trend = 0.002, respectively) compared to those in the lowest tertile. No associations are observed between low fat milk, yogurt, cheese or fermented dairy consumption, and changes in cognitive performance. Conclusion:Results suggest there are no clear prospective associations between consumption of most commonly consumed dairy products and cognition, although there may be an association with a greater rate of cognitive decline over a 2-year period in older adults at high cardiovascular disease risk for whole-fat milk., This work was supported by the official Spanish Institutions for funding scientific biomedical research, CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), and Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigación para la Salud (FIS), which is cofunded by the European Regional Development Fund (six coordinated FIS projects leaded by J.S.-S. and J.Vi., including the following projects: PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/ 02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/ 01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/ 00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/ 01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/00017, PI19/01226, PI19/ 00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158); the Especial Action Project entitled: Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-Plus grant to JS-S.; the European Research Council (Advanced Research Grant 2014– 2019; agreement #340918) granted to MÁM-G.; the Recercaixa (number 2013ACUP00194) grant to JS-S.; grants from the Consejería de Salud de la Junta de Andalucía (PI0458/2013, PS0358/2016, PI0137/2018); the PROMETEO/2017/017 and PROMETEO/2021/021 grants from the Generalitat Valenciana; the SEMERGEN grant; Juan de la Cierva–Incorporación research grant (IJC2019-042420-I) of the Spanish Ministry of Economy, Industry and Competitiveness and European Social Funds to JK. This research was also partially funded by EU-H2020 Grants (Eat2beNICE/ H2020-SFS-2016-2; and the Horizon 2020 PRIME study (Prevention and Remediation of Insulin Multimorbidity in Europe; grant agreement #847879). J.N. is supported by a predoctoral grant from Ministerio de Ciencia, Innovación y Universidades (FPU 20/00385). SKN is supported by a postdoctoral fellowship from the Canadian Institutes of Health Research (CIHR). C.G.-M. is supported by a predoctoral grant from the University of Rovira I Virgili (2020PMF-PIPF-37). I.P.-G. is supported by a predoctoral grant from Ministerio de Ciencia, Innovación y Universidades (FPU 17/01925). J.S.-S., senior author of this paper, was partially supported by ICREA under the ICREA Academia program.